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            Budding yeast has served as an excellent model organism for studying 
endocytosis in eukaryotes. One of the most debated topics in this field has been the 
role of actin in the endocytic process. Only when the high-resolution, dual-labeling 
and realtime fluorescence microscopy emerged, has the direct contribution of actin to 
endocytosis been observed. A growing body of evidence indicates that a dynamic 
actin cytoskeleton is indispensable for plasma membrane remodeling, invagination 
and vesicle scission during the clathrin-mediated endocytosis. Furthermore, actin 
polymerization that drives the internalization process is tightly regulated, as transient 
bursts of actin polymerization are precisely coordinated with the recruitment of other 
endocytic proteins. Hence studies on the control of the actin dynamics will shed light 
on the regulatory complexity of endocytosis. By far, the best understood mechanism 
of turning off actin polymerization machinery at the nascent vesicle is 
phosphorylation by Prk1p family kinases. One of the phosphorylation targets is the 
multivalent protein Pan1p, which is responsible for organizing the vesicle coat, 
tethering the coat to the actin meshwork by physically binding to F-actin, and 
activating Arp2/3 complex for actin nucleation. Thus, Pan1p plays a pivotal role in 
coupling the endocytic coat with the force-generating actin polymerization. 
Phosphorylation of Pan1p by Prk1p inhibits its activity and ultimately triggers the 
disassembly of the coat and termination of actin polymerization at the vesicle.  
This thesis work started with the exploration of additional Prk1p 
phosphorylation targets based on the biochemical characterization of the substrate 
specificity of the kinase. After an extensive mutagenic analysis on its native substrate 
Pan1p, Prk1p was shown to recognize the minimal phosphorylation motif 
[L/I/V/M]-X-X-X-X-T-G [Chapter 3]. Containing three tandem copies of this 
 xii
consensus sequence, endocytic protein Scd5p was in turn predicted and validated as a 
novel regulatory target for Prk1p [Chapter 4]. 
The identification of Scd5p as another Prk1p target was then conceived to 
offer an exciting opportunity to investigate a major unanswered question in the 
regulatory pathway of actin-driven endocytosis. Considering the inhibitory role for 
Prk1p phosphorylation, it is likely that one or more phosphatases may be necessary to 
counteract the kinase and reactivate its targets such as Pan1p. The identity of the 
phosphatase [s] that relieves Pan1p and other phosphorylated proteins from the 
phosphoinhibition, was unclear. Immediately, the type I phosphatase Glc7p and its 
targeting subunit Scd5p emerged as an attractive candidate. In this thesis work, it was 
demonstrated that scd5-1 mutant with an impaired binding to the phosphatase, caused 
many deleterious effects on endocytosis and actin organization. More importantly, 
these defects can be rescued simply by removal of the kinase Prk1p, consistent with 
the proposed role of Scd5p-Glc7p in balancing the kinase activity. However, to 
establish that dephosphorylation and reactivation of Prk1p targets are dependent on 
the phosphatase, it was imperative to provide direct evidence that Scd5-Glc7p 
dephosphorylates Pan1p. Subsequently, this study employed various approaches to 
confirm that Pan1p is indeed dephosphorylated specifically by the Scd5p-Glc7p 
phosphatase complex in vitro and in vivo. In addition, it was also revealed that, End3p, 
a Pan1p-binding partner, exhibits high affinity for Scd5p and enhances the 
recruitment of the phosphatase to phosphorylated Pan1 tremendously. Live cell 
imaging of fluorescently-labeled Prk1p, Scd5p and Pan1p, has allowed us to construct 
a spatiotemporal map of phosphoregulation of actin-driven endocytosis [Chapter 5]. 
This finding completes the other half of the cycle of phosphoregulation of endocytosis 


































1.1 Endocytosis: from mammals to yeast  
1.1.A   Endocytosis in mammals 
Plasma membrane marks the interface between intracellular and extracellular 
environment for a cell and is critical for vital cellular functions including defense 
against pathogens and toxins, cell motility and homeostasis maintenance. One 
membrane-originated process, namely endocytosis, plays a critical role in control of 
the protein and lipid composition of the plasma membrane, regulation of signaling 
pathways, control of cell surface area, and uptake of nutrients. Endocytosis has been 
well documented and thoroughly studied in mammalian systems. Several distinct 
endocytic pathways were categorized based on their distinct machineries for 
internalization. These pathways include the clathrin-dependent pathway, the caveolar 
pathway, a clathrin- and caveolae-independent pathway, macropinocytosis, and 
phagocytosis. First, clathrin-mediated endocytosis is the major pathway and is 
involved in the recycling of synaptic vesicles at nerve terminals (Brodin et al., 2000; 
Brodsky et al., 2001; Jarousse & Kelly, 2001). Second, internalization via caveolae is 
much less well understood but appears to have a role in cholesterol homeostasis, 
recycling of glycosyl-phosphatidylinositol [GPI]-anchored proteins, glycosphingolipi
d transport, transcytosis of serum components, and uptake of certain viruses (Razani 
& Lisanti, 2001). The third pathway is macropinocytosis involving the engulfment of 
extracellular fluid and phagocytosis for engulfment of particles such as invading 
bacteria (Dramsi & Cossart, 1998; Galan, 2001). Despite the obvious differences, all 
three endocytic pathways require remodeling of the cell cortex during the 
internalization step. For the clathrin- and caveolae-dependent pathways, invaginations 
of the plasma membrane are formed, whereas for macropinocytosis and phagocytosis, 





transport of vesicles away from the plasma membrane, vesicle uncoating, fusion to 
other membrane compartments, and sorting of cargo for degradation or recycling.  
Much of our fundamental understanding of endocytosis came from astute 
interpretations of morphology that were made 20–40 years ago. In 1964, Thomas 
Roth and Keith Porter (T. F. Roth & Porter, 1964) first described the basic aspects of 
clathrin-coated-pit formation, relying on the analysis of electron micrographs. Using 
electron microscopy [EM], the clathrin, AP-2, adaptor complexes, and dynamin were 
identified as major components of the coats of endocytic pits at the plasma membrane 
(Munn, 2001; Schmid, 1997). However EM was limited from further investigation of 
the highly dynamic endocytic process, because it requires samples to be fixed and 
therefore frozen in time (M. G. Roth, 2006). More mechanistic insights into 
endocytosis could only be gained through live cell fluorescence microscopy, which 
monitors the process in real-time in living cells.   
 
1.1.B   Endocytosis in yeast 
The budding yeast Saccharomyces cerevisiae has served as an excellent model 
organism for the study of vesicular transport with its ease of genetic manipulation and 
availability of the completed genome sequence (Goffeau et al., 1996). Furthermore, a 
vast collection of well-characterized mutants affected in almost every aspect of 
cellular physiology is available (Pringle et al., 1997).  
Yeast cells do carry out endocytosis, necessary for internalization of mating-
factor receptors, nutrient permeases and other surface proteins including chitin 
synthases. Initial attempts to identify components of the endocytic machinery in 
budding yeast was to screen for mutants defective in the internalization of membrane-





isolation of the end3 and end4 [sla2] mutants (Raths et al., 1993) and subsequently to 
the isolation of the end5 [vrp1], end6 [rvs161], and end7 [act1] mutants (Munn et al., 
1995). Emr and colleagues isolated dim mutants defective in internalization of the 
lipophilic dye FM4-64 as a second type of screen for endocytic mutants (Wendland et 
al., 1996). In addition, several mutants defective in fluid-phase endocytosis have been 
scored by measuring uptake of the membrane-impermeant fluorescent dye lucifer 
yellow [LY] (Riezman, 1985).  
Genetic screens were also designed to search for high copy suppressor[s] for 
these end mutants. Via this approach, LAS17 [local anaesthetic sensitive 17] gene was 
identified to be able to suppress the end5 mutant (Naqvi et al., 1998). Further 
investigation revealed that Las17p binds to Vrp1p and is necessary for proficient 
endocytosis (Madania et al., 1999). In addition, many functionally related proteins to 
the already studied end mutants were also examined for potential roles in endocytosis. 
These group of proteins include the actin-filament-bundling protein fimbrin [encoded 
by suppressor of actin 6, SAC6 gene] (Kubler & Riezman, 1993), actin-dependent 
type I myosins [Myo3p, Myo5p] (Geli & Riezman, 1996), the actin-filament-severing 
protein coflin [encoded by COF1] (Lappalainen & Drubin, 1997), and actin-related 
protein 2 [Arp2p] (Moreau et al., 1997; Moreau et al., 1996). Thus far, over 50 genes 
have been demonstrated to be important for receptor-mediated endocytosis (Engqvist-
Goldstein & Drubin, 2003). The majority of these genes encode proteins that either 
have homologues in mammalian cells or have domains that share homology with 








1.2 Actin cytoskeleton and endocytosis 
1.2.A   Evidence of actin’s involvement in endocytosis 
Most of the proteins required for mammalian endocytic internalization are also 
present in the budding yeast. Studying endocytosis in yeast with powerful molecular 
genetics technique has made one of the many groundbreaking discoveries - the 
important role of actin cytoskeleton in the endocytic process.  
The first line of evidence came from the observation that the internalization 
step of the endocytosis of mating pheromone α-factor was defective in an actin mutant 
[act1-1] (Kubler & Riezman, 1993). Moreover, endocytosis-defective mutant end7 
isolated in a later screen turned out to be the actin gene itself (Munn et al., 1995). 
More hints came from the experiments where yeast cells were treated with 
pharmacological agents to interfere with actin turnover. It was found that endocytosis 
was completely blocked upon treatment with latrunculin A, which binds to actin 
monomers and prevents their assembly into filaments, or jasplakinolide, an actin-
filament stabilizer (Ayscough, 2000; Ayscough et al., 1997). When treating 
mammalian cells with these actin poisons, endocytic uptake and the formation of 
coated vesicles were appreciably inhibited, but not completely blocked as observed in 
yeast cells (Fujimoto et al., 2000; Gottlieb et al., 1993; Lamaze et al., 1997), implying 
a differential requirement of actin for endocytosis in these two systems.  
 
1.2.B   Actin and endocytosis in mammals 
In mammalian cells, growing evidence indicates that actin is essential for the 
formation of membrane protrusions for macropinocytosis and phagocytosis (May & 
Machesky, 2001; Welch & Mullins, 2002) and caveolae-mediated endocytosis 





clathrin-mediated endocytosis, actin may not play an obligatory role in all cell types. 
The first compelling evidence for the participation of actin in clathrin-mediated 
endocytosis in mammalian cells was obtained based on high-resolution, dual-labeling 
and real-time fluorescence microscopy. It was clearly described that transient bursts 
of actin polymerization occur near the end of the lifetime of the clathrin-coated pit 
and overlap with the internalization of clathrin-coated vesicle (Merrifield et al., 2002; 
Yarar et al., 2005). Actin polymerization is therefore tightly coupled both spatially 
and temporally to the vesicle formation. Dynamic actin filaments were also reported 
to be attached to endosomes in fibroblast cells (Kaksonen et al., 2000) and Xenopus 
eggs (Taunton et al., 2000). Actin “comet tails” are formed on one side of the 
endosomes [Fig. 1-1] and thought to push the endosomes for making contact with 
microtubules, which are the tracks for vesicle trafficking. 
 
1.2.C   Actin and endocytosis in yeast 
Actin cytoskeleton in yeast cells exists in three forms: actin cables, an actin-
myosin contractile ring, and cortical actin patches (Pruyne & Bretscher, 2000a, 
2000b). Cables are F-actin bundles that serve as tracks for anterograde and retrograde 
cargo movement (Boldogh et al., 2001; Huckaba et al., 2004; Yang & Pon, 2002) [Fig. 
1-1]. The actin-myosin contractile ring forms transiently at the mother-daughter neck 
and is important for cytokinesis (Adams & Pringle, 1984). The cortical actin patches 
are highly dynamic structures that undergo constant turn-over. They are formed at the 
plasma membrane and move rapidly into the cell interior afterwards (Ayscough et al., 
1997; Doyle & Botstein, 1996; Smith et al., 2001; Waddle et al., 1996). 
Conspicuously more than 30 out of the 50 proteins important for endocytic 






Actin-implicated processes in yeast and mammalian cells.  
The dynamic polymerization of actin filaments [red] is involved in different processes 
that reshape or move cellular membranes. These processes include different forms of 
endocytic uptake at the plasma membrane — that is, clathrin-mediated endocytosis in 
S. cerevisiae and mammalian cells, as well as caveolae-mediated endocytosis, 
macropinocytosis and phagocytosis in mammalian cells. In addition, actin assembly 
has a role in the movement of endosomes and/or endocytic vesicles. In mammalian 
cells, endosomes move by actin “rocketing”, whereas in S. cerevisiae, endocytic 
vesicles move together with actin cables as they are being assembled by formin 
proteins. Finally, the protrusion of lamellipodia and filopodia in migrating 
mammalian cells is dependent on actin polymerization. [Figure reproduced with 






partially with cortical actin patches (Engqvist-Goldstein & Drubin, 2003; Smythe & 
Ayscough, 2006), indicating a functional link between the cortical actin patches and 
endocytic machinery. An important advance in understanding the specific role of actin 
  
 Fig 1-2 
 
Role of actin cytoskeleton in yeast endocytic internalization.  
This schematic diagram illustrates putative functions of different actin-cytoskeleton 
proteins during endocytic internalization in S. cerevisiae. Las17p, the yeast homology 
of Wiskott–Aldrich syndrome protein [WASP] together with the myosins Myo3p and 
Myo5p activate the Arp2/3 complex at the cell surface. Myosins might also generate 
force on the actin network or anchor the actin filaments to the plasma membrane 
through their motor domains. The activated Arp2/3 complexes form branched actin 
filaments that grow through the addition of ATP–actin monomers near the plasma 
membrane. Older filaments are capped at their barbed ends by capping proteins 
[Cap1/2p]. The branched filaments are further crosslinked by Sac6p [fimbrin]. The 
crosslinked actin network is linked to the underlying vesicle coat by actin-binding 
proteins such as Sla2p and Pan1p, which are represented by green hand-like structures. 
The growth of the actin network leads to the invagination of the coated membrane. 







in endocytosis was the discovery that cortical actin patches mark endocytic sites at the 
plasma membrane and nascent endocytic vesicles (Huckaba et al., 2004; Kaksonen et 
al., 2003; Kaksonen et al., 2005; Newpher et al., 2005). Furthermore, clathrin and  
other endocytic proteins were also found to colocalize with the actin patches 
(Kaksonen et al., 2005; Newpher et al., 2005). The short lifetime of the actin patches 
[around 15 seconds] is divided into an initial phase of restricted motility followed by a 
phase of rapid motility during which the patch disassembles (Kaksonen et al., 2003). 
The initial phase coincides with the internalization movement of clathrin-coated 
endocytic structures (Kaksonen et al., 2005) [Fig. 1-2] and the rapid motility phase 
corresponds to the movement of clathrin-uncoated, actin-filament-covered endocytic 
vesicles (Huckaba et al., 2004; Toret & Drubin, 2006).  
 
1.3 How does actin drive endocytosis in yeast?  
1.3.A   Yeast endocytic pathway 
Using genetics and high-resolution quantitative real-time microscopy, key 
players for the yeast endocytosis have been functionally delineated into the various 
steps of internalization (Kaksonen et al., 2005), including, endocytic site initiation, 
membrane invagination and scission, and vesicle release [Fig. 1-3]. Based on the 
spatiotemporal dynamics, these proteins were grouped in four modules, namely, [1] 
the coat, [2] the actin network growth machinery, [3] the actin dynamic regulation 
module, and [4] two amphiphysin proteins Rvs161p and Rvs167p, as illustrated in Fig. 
1-3 (Ayscough, 2005; Kaksonen et al., 2005).  
The most extensively studied endocytic process in yeast is the internalization 
of the pheromone α-factor receptor Ste2p. The molecular choreography of this 





Drubin, 2006). First, protein structures named eisosomes organize endocytic sites at 
the plasma membrane (Walther et al., 2006) along with Ede1p, clathrin, and its 
adaptors including yeast epsins and AP180s (Newpher et al., 2005; J. Y. Toshima et 
al., 2006). Upon the arrival of these early endocytic factors, Ste2p receptors with 
bound α-factor tend to cluster at the endocytic site (J. Y. Toshima et al., 2006). One 
or two minutes after the arrival of clathrin, more coat module proteins like Pan1p, 
End3p, Sla1p and Sla2p start to be recruited. 
 














The sequential assembly of proteins at endocytic sites. 
A. The different steps of endocytic internalization: endocytic site initiation, membrane 
invagination and scission, and vesicle release. The four protein modules are 
shown schematically: the coat [green], the WASP–myosin complex [yellow], the 
actin network [red] and the amphiphysin complex [blue]. Components of these 
different protein modules are assembled and disassembled dynamically.  
B. The temporal localization of the constituent proteins for each module.  






Simultaneously, Las17p will encircle the coat and prepare for the initiation of 
Arp2/3-mediated actin polymerization on the plasma membrane. The arrival of Bzz1p 
[activator of Las17p] and Vrp1p-type I myosins triggers the start of actin filament 
nucleation [Las17p and type 1 myosins are potent Arp2/3 complex activators (Sun et 
al., 2006)]. Continued nucleation leads to the formation of a cone of crosslinked actin 
filaments tethered to the endocytic coat. This growing actin network cooperates with 
myosin motor activity (Sun et al., 2006) to pull the attached coat inwards and 
invaginates the underlying membrane [Fig. 1-2]. As the vesicle coat continues 
growing, the amphiphysins Rvs161p and Rvs167p are recruited to the endocytic site  
for the release of the forming vesicle (Kaksonen et al., 2005). After the coat has 
moved inwards approximately 200 nm, the coat and WASP/myosin module are 
disassembled. Uncoated and uncoupled from actin meshwork, the endocytic vesicle is 
then fused with endosomes [Fig. 1-1], which is facilitated by actin cables (J. Y. 
Toshima et al., 2006).  
 
1.3.B   Coupling and uncoupling the actin engine with the endocytic coat 
Actin polymerization drives internalization. This is made possible by scaffold 
proteins that can physically link the force-generating actin engine with the endocytic 
coat. Candidate coupling proteins include coat module protein Sla2p (Engqvist-
Goldstein et al., 1999; Henry et al., 2002; Kaksonen et al., 2003) and Pan1p 
(Kaksonen et al., 2005; J. Toshima et al., 2005) for their capabilities to bind to actin 
filaments [Fig. 1-2].  
Turning off actin polymerization and uncoupling actin meshwork from the 
newly formed vesicles are the prerequisite for their proper docking and fusion with 





Las17p activity on Arp2/3 complex (D'Agostino & Goode, 2005). Second, Abp1p 
recruits Prk1p family kinases to phosphorylate relevant targets on the coat, including 
Pan1p, Sla1p and yeast epsins (Sekiya-Kawasaki et al., 2003; Watson et al., 2001; 
Zeng & Cai, 1999; Zeng et al., 2001), resulting in coat disassembly. Inhibiting the 
kinases Ark1p and Prk1p leads to the accumulation of clusters of actin filament-
covered endocytic vesicles, highlighting the necessity of  uncoupling the actin engine 
from the endocytic coat (Cope et al., 1999; Sekiya-Kawasaki et al., 2003). 
 
1.4 Earlier discoveries made in our lab  
Cellular morphogenesis is important for proper cell growth and division in the 
budding yeast. It involves polarization of secretion toward specific sites at the plasma 
membrane. Yeast cells, surrounded by a cell wall, are able to generate an osmotic 
gradient across the plasma membrane so as to drive growth (Harold, 1990). 
This turgor pressure is isotropic, but growth is channeled to specific sites by 
directional delivery of wall modifying enzymes and new cell wall constituents to 
these sites. The cells then must know how to target this delivery and how to choose 
the sites of growth. The actin cytoskeleton has been implicated in these processes. 
Cortical structures containing actin filaments cluster at sites of cell growth during the 
cell cycle (Adams & Pringle, 1984), as previously described in Section 1.2C.  
Mutations in actin gene itself, actin-cross linker or capping proteins all lead to 
disrupted vectorial secretion and more uniform expansion (Lew & Reed, 1993). All 
these data are indicative of the role played by the actin cytoskeleton in specifying sites 
for the delivery of secretory vesicles. Subsequently it was reported that the dynamic 
reorganization of the actin cytoskeleton is controlled, directly or indirectly, by the 





An attempt to identify additional factors in regulating the dynamic re-
arrangements of actin cytoskeleton was made to screen for mutants that would lose 
viability rapidly at restrictive temperature in the background of cdc28-4. By this 
approach pan1-4 mutant was isolated, exhibiting gross defects in actin organization 
(Tang & Cai, 1996).  
The discovery that Pan1p is an essential protein required for normal actin 
organization laid the foundation of many important subsequent findings in our lab. 
For instance, END3 gene was isolated in a screening for multicopy suppressors of 
pan1-4 mutant (Tang et al., 1997). The physical interaction with End3p in vivo (Tang 
et al., 1997) enables Pan1p to functionally link the actin cytoskeleton with 
endocytosis. Another genetic screening for the extragenic suppressor of pan1-4 led to 
the identification of PRK1 gene (Zeng & Cai, 1999). Deletion of the gene encoding a 
serine/threonine kinase was sufficient to rectify the actin abnormalities in pan1-4 
mutant (Zeng & Cai, 1999). Further work to characterize the kinase Prk1p revealed 
that it could phosphorylate threonines in multiple LxxQxTG motifs found in Pan1p 
and another endocytic adaptor Sla1p (Zeng et al., 2001). The physiological relevance 
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2.1     Materials 
           All the chemicals and reagents were purchased from BDH laboratory supplies 
[UK] and Sigma Chemical Company [USA] unless otherwise stated. The components 
used in media preparation were purchased from DIFCO Laboratory [USA] and Sigma 
Chemical Company [USA]. 
           Restriction enzymes and DNA modifying enzymes were from New England 
Biolabs [USA], Amersham [UK], and Boehringer Mannheim [Germany]. 
 
2.2     Strains and growth conditions 
           The E. coli strain DH5α [GIBCO BRL, USA] was used throughout the study 
for all cloning procedures. For the expression of GST-fusion proteins, the E. coli 
strain BL21 [Novagen, USA] was used. E. coli cells were either cultured in LB broth 
[1% bacto-tryptone, 0.5% bacto-yeast extract, 1% NaCl, pH 7.0] or maintained on LB 
agar plates [LB containing 2% bacto-agar] at 37°C. When recombinant plasmid-
containing cells were cultured, the media were supplemented with 100 μl/ml of 
ampicillin [Sigma].  
           Yeast strains used in this study were derived from W303, except for SFY526 
used in the two-hybrid assay [Table 1]. Pan1-GFP or Abp1-RFP harboring strains 
were derived from parental strain DDY3063 [courtesy of David Drubin]. Yeast cells 
were cultured in rich medium [YPD], synthetic complete medium [SC] or SC lacking 
the appropriate amino acids for plasmid maintenance. All media were prepared as 
described in (Rose et al., 1990). YPD medium contained 1.1% yeast extract, 2.2% 
peptone, 0.006% adenine and 2% glucose. SC medium contained 0.67% yeast 
nitrogen base without amino acids, 2% glucose and 0.2% amino-acids mix. 
Sporulation medium contained 0.2% yeast extract, 2% potassium acetate and 0.1% 
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glucose. For preparation of solid media, 2% of bacto-agar was added. To induce the 
expression of genes under the GAL1 promoter, raffinose was used as the carbon 
source and galactose was later added to a final concentration of 2%. Wild-type cells 
were cultured at 30°C, whereas temperature-sensitive mutants were grown at the 
permissive temperature of 25°C and analyzed at the restrictive temperature of 37°C, 




Table 1. Yeast strains used in this study 
   
 Name                                 Genotype and Source 
 
W303-1A        MATa ade2 can1 trp1 leu2 his3 ura3.  
W303-1B MATα ade2 can1 trp1 leu2 his3 ura3.  
SFY526 MATa ade2 canr trp1 leu2 his3 ura3 lys2 gal4 gal80 URA3::GAL1-lacZ. [Clontech 
Laboratories, USA]            
DDY3063 MATα his3-Δ200 ura3-52 leu2-3,112 lys2-801 PAN1-GFP::HIS3 ABP1-RFP::HIS3 
[courtesy of David Drubin] 
YMC422  MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1-4 
YMC441  MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1::PAN1-Myc-
URA3 




MATα  ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5-1  
prk1Δ::URA3 scd5-1  
YMC448 MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5-HA-LEU2
  
YMC449  MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5AAA-HA-
LEU2 
YMC471 MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5-HA-LEU2 
pan1::PAN1-Myc-URA3  




MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5AAA-HA-
LEU2 pan1::PAN1-Myc-URA3  
YMC474  MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 end3Δ::HIS3  
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YMC476 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 end3Δ::HIS3 
scd5::SCD5-HA-LEU2 
YMC477  MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 prk1Δ::HIS3  
YMC478 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 prk1Δ::HIS3 
pan1::PAN1-Myc-URA3 
YMC479  MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5-1 pan1::PAN1-
Myc-URA3 
YMC480 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 end3Δ::HIS3 
pan1::PAN1-Myc-URA3 
YMC481 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 glc7::GLC7-HA-LEU2 
YMC482 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1::PAN1-Myc-
URA3 glc7-T152K [glc7::GLC7T152K-HA-LEU2] 
YMC483  MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1::PAN1-Myc-
TRP1 
YMC484 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1::PAN1-Myc-
TRP1 glc7-td [glc7::GLC7-td-URA3] 
YMC485 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1::PAN1-Myc-
TRP1 glc7-ntd [glc7::GLC7-ntd-URA3] 
YMC486 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 prk1Δ::TRP1 
YMC487           MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5Δ::HIS5 pSCD5-
HA-316 
YMC488           MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 prk1Δ::TRP1 
scd5Δ::HIS5 pSCD5-HA-316 
YMC489 MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5PBM2Δ-HA-
LEU2 
YMC490          MATα ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5Δ::HIS5 pSCD5-
HA-316 glc7::GLC7T152K-Myc-LEU2 
YMC491 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5-Myc-
TRP1 
YMC492 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5-Myc-
TRP1 glc7-ntd [glc7::GLC7-ntd-URA3] 
YMC493 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5-Myc-
TRP1 glc7-td [glc7::GLC7-td-URA3] 
YMC494 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1::PAN1-GFP-
HIS3MX 
YMC495 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 prk1::PRK1-GFP-
LEU2 
YMC496 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 scd5::SCD5-GFP-
HIS3MX 
YMC497 MATa ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 ura3-1 pan1::PAN1-CFP-
TRP1 prk1::PRK1-GFP-LEU2 
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2.3     Recombinant DNA methods 
           General recombinant DNA methods were performed essentially as described 
by (Sambrook et al., 1989). Polymerase chain reaction [PCR] was carried out with 
Vent DNA polymerase. Purification of PCR products was done using QIAquick PCR 
Purification Kit [QIAGEN, Japan]. Restriction enzyme digests were performed using 
the appropriate buffers supplied by the manufacturers. T4 DNA ligase was used for 
ligation of DNA fragments.  
 
2.3.A    Plasmid DNA preparation and analysis 
Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit [QIAGEN, 
Japan]. The isolated plasmid DNA was subjected to restriction enzyme digests and 
analyzed by electrophoresis using a horizontal agarose gel containing 50 μg/ml 
ethidium bromide in Tris-borate buffer [45 mM Tris-borate, 1 mM EDTA], with 1 kb 
DNA markers from New England Biolabs [USA] as molecular size standards. Gel 
recovery of digested plasmid DNA or PCR product was achieved using the QIAquick 
Gel Extraction Kit [QIAGEN, Japan].  
 
2.3.B    Site-directed mutagenesis 
The in vitro site-directed mutagenesis was performed using overlap extension 
PCR technique illustrated in Fig. 2-1 (Ho et al., 1989). Two complementary primers 
[MF and MR] were synthesized where the intended mutational sequences were ideally 
located in the middle. Two rounds of PCR gave rise to the mutant PCR product, and it 
was then cloned into appropriate vectors and verified by DNA sequencing. The same 
strategy and/or slight modification were employed to create all the sequence 
substitution and gene truncations.  
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Fig 2-1 
 
Schematic diagram of site-directed mutagenesis by overlap extension.  
The double-stranded DNA and synthetic primers are represented by lines with arrows 
indicating the 5’-to-3’ orientation. The site of mutagenesis is indicated by the small 
red rectangle. The shaded portion of the figure represents the proposed intermediate 
steps taking place during the course of reaction [3], where the denatured fragments 
anneal at the overlap and are extended 3’ by DNA polymerase [dotted line] to form 
the mutant fusion product. By adding additional primers ‘F’ and ‘R’ the mutant fusion 





2.4     Plasmid constructions 
All the yeast - E. coli shuttle plasmids used in this study are listed in table 2.  
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Table 2. Plasmids used in this study 
 
Name                                                  Characteristics and Source 
 
pRS304 Integration vector containing TRP1 (Sikorski & Hieter, 1989).  
pRS305 Integration vector containing LEU2 (Sikorski & Hieter, 1989).  
pRS306 Integration vector containing URA3 (Sikorski & Hieter, 1989).  
pRS313 CEN6 HIS3 vector (Sikorski & Hieter, 1989). 
pRS314 CEN6 TRP1 vector (Sikorski & Hieter, 1989).  
pRS315 CEN6 LEU2 vector (Sikorski & Hieter, 1989).  
pRS316 CEN6 URA3 vector (Sikorski & Hieter, 1989). 
pRS424 2μ TRP1 vector (Christianson et al., 1992). 
pRS425 2μ LEU2 vector (Christianson et al., 1992). 
pRS426 2μ URA3 vector (Christianson et al., 1992). 
pGEX-4T-1   Glutathione S-transferase fusion vector (Smith & Johnson, 1988). 
pGBKT7 2μ TRP1, GAL4 DNA binding domain [1-147 a.a.] [Clontech Laboratories.]           
                                                           
pGADT7 2μ LEU2, GAL4 activation domain [768-881 a.a.] [Clontech Laboratories.] 
 
pYHT1 pGST-LR1; PAN1 [99-383 a.a., the first long repeat] in  pGEX-4T-1. 
pYHT2 pGST-LR2; PAN1 [383-900 a.a., the second long repeat] in  pGEX-4T-1. 
pYXW4 pRS306-PAN1c-Myc; PAN1[1252-1480 a.a.] tagged with Myc at the C-terminus 
in pRS306. 
pYGS40 pRS314-GAL-PRK1; PRK1 under GAL1 promoter control in pRS314.  
pYGS57 pRS315-GAL-PRK1; PRK1 under GAL1 promoter control in pRS315. 
pYGS66 pRS316-GAL-HA-PRK1; HA-tagged PRK1 under GAL1 promoter  control in 
pRS316.  
pYGS89 pGST-R15T; PAN1 [564-846 a.a.] in pGEX-4T-1.  
pYGS96 pRS314-GAL-HA-PRK1D158Y; HA-tagged PRK1D158Y under GAL1 promoter 
control in pRS314.  




pGAL-STE3-EGFP; STE3 coding region with a C-terminal EGFP epitope 
followed by the ADH1 terminator, and placed under GAL1 promoter control in 
pRS314. 
pYHT848 pEND3-316; The END3 gene was generated by PCR and cloned into pRS316. 
pYHT1148 pEND3-314; The END3 gene was generated by PCR and cloned into pRS314. 
pYHB235 pSCD5-424; The SCD5 gene was generated by PCR and cloned into pRS424. 
pYTH1106 pEND3-424; The END3 gene was generated by PCR and cloned into pRS424. 
pYHT1222 pPAN1-314; The PAN1 gene was generated by PCR and cloned into pRS314. 
pYHT837 pPAN1-316; The PAN1 gene was generated by PCR and cloned into pRS316. 
pYGS194 pPRK1c-GFP-305; PRK1 [439-810 a.a.] tagged with GFP at the C-terminus in 
pRS305.  
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pNSP28 pPAN1c-CFP-304; PAN1 [1252-1480 a.a.] agged with CFP at the C-terminus in 
pRS304.  
pNSP76 pET-SCD5-N1 [His-SCD5-N1]; DNA fragment encoding Scd5p [1-301 a.a.] was 
cloned into pET-32a.                                                                                                      
pNSP77 pET-SCD5-N2 [His-SCD5-N2]; DNA fragment encoding SCD5p [302-534 a.a.] 
was cloned into pET-32a.                                                                                              
pNSP75 pET-SCD5-C [His-SCD5-C]; DNA fragment encoding SCD5p [535-872 a.a.] was 
cloned into pET-32a.                                                                                                      
pNSP40 pPAN1-LR1-AD;  DNA fragment encoding Pan1p [1-385 a.a.] was cloned into 
pGADT7. 
pNSP41 pPAN1-LR2-AD; DNA fragment encoding Pan1p [384-713 a.a.] was cloned into 
pGADT7. 
pNSP42 pPAN1-CC-AD; DNA fragment encoding Pan1p [641-1310 a.a.] was cloned into 
pGADT7. 
pNSP43 pPAN1-PP-AD; DNA fragment encoding Pan1p [1239-1480 a.a.] was cloned into 
pGADT7. 
pYGS251 pEND3n-BD; DNA fragment encoding End3p [1-141 a.a.] was cloned into 
pGBKT7. 
 
pYGS259 pEND3c-BD; DNA fragment encoding End3p [72-349 a.a.] was cloned into 
pGBKT7. 
pYGS360 pSCD5-HA-316; The SCD5 gene was generated by PCR and cloned in frame with 



































pGEX-R15-T/S  GST-R15 with T to S mutation at P0 position. 
PGEX-R15-L/A GST-R15 with L to A mutation at P-5 position. 
pGEX-R15-LP-6  GST-R15 with PP-6 to L and LP-5 to A mutations. 
pGEX-R15-LP-4  GST-R15 with TP-4 to L and LP-5 to A mutations. 
pGEX-R15-LP-3  GST-R15  with AP-3 to L and LP-5 to A mutations. 
pGEX-R15-L/I   GST-R15  with L to I mutation at P-5 position. 
pGEX-R15-L/M GST-R15  with L to M mutation at P-5 position. 
pGEX-R15-L/P  GST-R15  with L to P mutation at P-5 position. 
pGEX-R15-L/V  GST-R15  with L to V mutation at P-5 position. 
pGEX-R15-L/T  GST-R15  with L to T mutation at P-5 position. 
pGEX-R15-L/S  GST-R15  with L to S mutation at P-5 position. 
pGEX-R15-L/N  GST-R15  with L to N mutation at P-5 position. 
pGEX-R15-L/F  GST-R15  with L to F mutation at P-5 position. 
pGEX-R15-L/W GST-R15  with L to W mutation at P-5 position. 
pGEX-R15-LN   GST-R15  with Q to N mutation at P-2 position. 
pGEX-R15-IN   GST-R15  with LP-5 to I and QP-2 to N mutations. 
pGEX-R15-VN  GST-R15  with LP-5 to V and QP-2 to N mutations. 
pGEX-R15-MN GST-R15  with LP-5 to M and QP-2 to N mutations. 
pGEX-R15-NA GST-R15  with QP-2 to N and TP0 to A mutations. 
pGEX-R15-LT GST-R15  with Q to T mutation at P-2 position. 
pGEX-R15-IT GST-R15  with LP-5 to I and QP-2 to T mutations. 
pGEX-R15-VT GST-R15  with LP-5 to V and QP-2 to T mutations. 
pGEX-R15-MT GST-R15  with LP-5 to M and QP-2 to T mutations. 
pGEX-R15-TA GST-R15  with QP-2 to T and TP0 to A mutations. 
pGEX-R15-LS GST-R15  with Q to S mutation at P-2 position. 
pGEX-R15-IS GST-R15  with LP-5 to I and QP-2 to S mutations. 
pGEX-R15-VS GST-R15  with LP-5 to V and QP-2 to S mutations. 
pGEX-R15-MS GST-R15  with LP-5 to M and QP-2 to S mutations. 
pGEX-R15-SA GST-R15  with QP-2 to S and TP0 to A mutations. 
pGEX-R15-LV GST-R15  with QP-2 to V mutations. 
pGEX-R15-LF GST-R15  with QP-2 to F mutations. 
pGEX-R15-IL GST-R15  with LP-5 to I and QP-2 to L mutations. 
pGEX-R15-MM GST-R15  with LP-5 to M and QP-2 to M mutations. 
pGEX-R15-IA GST-R15  with LP-5 to I and QP-2 to A mutations. 
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pYHB195 
pYHB191 
pGEX-R15-ML GST-R15  with LP-5 to M and QP-2 to L mutations. 






pGEX-YAP1801-TAA, ATA, AAT, AAA, T/A and TTT; GST-YAP1801 [407-
637 a.a.] with only T413, T427, T453, none, T427/453 or all intact cloned in 





pYHB68,  69 
pYHB70,  54 
pGEX-ENT1-TAAAA, ATAAA, AATAA, AAATA, AAAAT, AAAAA, AT, 
TA, AA and WT; GST-ENT1 [272-454 a.a.] with only T346, T366, T395, T415, 
T427, none, T346/366/415/427, T346/366/395/427, T346/366/427 or all intact 




pGEX-SCD5-TAA, ATA, AAT, AAA and WT; GST-SCD5 [409-585 a.a.] with 
only T416, T450, and T490, none or all intact cloned in pGEX-4T-1 respectively. 
pYGS346 pSCD5c-HA; The DNA coding region for Scd5p [79-872 a.a.] was generated by 
PCR and cloned in frame with a C-terminal HA epitope followed by the ADH1 
terminator in pRS305. 
pYGS359 pSCD5PBM2Δc-HA; The DNA coding region for Scd5p [79-872 a.a.] containing 
mutations on its PBM2 [KKVRF to AKAAA] was generated by PCR and cloned 
in frame with a C-terminal HA epitope followed by the ADH1 terminator in 
pRS305. 
pYHB139 pSCD5AAAc-HA; The DNA coding region for Scd5p [79-872 a.a.] with T416A, 
T450A, and T490A mutations was generated by PCR and cloned in frame with a 
C-terminal HA epitope followed by the ADH1 terminator in pRS305. 
 
pYHB201 pSCD5-N-BD; DNA fragment encoding Scd5p [1-534 a.a.] was cloned into 
pGBKT7. 
pYHB132 pSCD5AAA-N-BD; DNA fragment encoding Scd5p [1-534 a.a.] with T416A, 
T450A, T490A mutations was cloned into pGBKT7. 
pYHB133 pSCD5EEE-N-BD; DNA fragment encoding Scd5p [1-534 a.a.] with T416E, 
T450E, T490E mutations was cloned into pGBKT7. 
pYGS352 pSCD5-C-BD; DNA fragment encoding Scd5p [535-872 a.a.] was cloned into 
pGBKT7. 
pYGS357 pSCD5-N1-BD; DNA fragment encoding Scd5p [1-301 a.a.] was cloned into 
pGBKT7. 
pYGS358 pSCD5-N2-BD; DNA fragment encoding Scd5p [302-534 a.a.] was cloned into 
pGBKT7. 
pYGS283 pSCD5-N-AD; DNA fragment encoding Scd5p [1-534 a.a.] was cloned into 
pGADT7. 
pYGS276 pSCD5AAA-N-AD; DNA fragment encoding Scd5p [1-534 a.a.] with T416A, 
T450A, T490A mutations was cloned into pGADT7. 
pYGS277 pSCD5EEE-N-AD; DNA fragment encoding Scd5p [1-534 a.a.] with T416E, 
T450E, T490E mutations was cloned into pGADT7. 
pYGS284 pSCD5-C-AD; DNA fragment encoding Scd5p [535-872 a.a.] was cloned into 
pGADT7. 
pYHT1074 pMyc-END3-314; DNA fragment encoding End3p [1-349 a.a.] was cloned in 
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pYHB340 pMyc-END3ΔC-314; DNA fragment encoding End3p [1-253 a.a.] was cloned in 
frame with an N-terminal Myc epitope and placed under its own promoter control 
in pRS314. 
pYHB338 pMyc-END3ΔΝ-314; DNA fragment encoding End3p [116-349 a.a.] was cloned 
in frame with an N-terminal Myc epitope and placed under its own promoter 
control in pRS314. 
pYHB307 pEND3ΔC-314; DNA fragment encoding End3p [1-253 a.a.] was placed under its 
own promoter control in pRS314. 
pYHB306 pEND3ΔΝ-314; DNA fragment encoding End3p [116-349 a.a.] was placed under 
its own promoter control in pRS314. 
pYHB143 pGLC7-BD; The GLC7 coding region was generated by PCR and cloned in frame 
into pGBKT7. 
pYHB371 pGLC7c-HA-305; DNA fragment encoding Glc7p [60-312 a.a.] with its upstream 
501 base pairs [bp] of the intron was cloned in frame with a C-terminal HA 
epitope followed by the ADH1 terminator in pRS305. 
pYHB266 pGLC7T152Kc-HA-305; T152K mutation was introduced into pGLC7c-HA-305 by 
PCR mutagenesis. 
pYHB322 pGLC7n-td-306 [Ub-Arg-DHFRts-HA-GLC7n-306]; The first 200 bp of the GLC7 
open reading frame was generated by PCR and cloned into HindIII site of the 
plasmid pPW66R (Dohmen et al., 1994; He & Moore, 2005). 
pYHB347 pGLC7n-ntd-306 [Ub-Arg-DHFRWT-HA-GLC7n-306]; The Leu residue at  
position 66 in the DHFR moiety of pUb-Arg-DHFRts-HA-GLC7n-306 was 
changed into Pro by PCR mutagenesis. 
pYHB255 pGLC7T152Kc-Myc-305; DNA fragment encoding Glc7p [60-312 a.a.] with T152K 
mutation was cloned in frame with a C-terminal Myc epitope followed by the 
ADH1 terminator in pRS305. 
pYGS409 pSCD5c-Myc-304; DNA fragment encoding Scd5p [79-872 a.a.] was cloned in 
frame with a C-terminal Myc epitope followed by the ADH1 terminator in 
pRS304. 
pYHB1 pRS316-GAL-ARK1c-HA; The DNA coding region for ARK1 [1-638 a.a.] in 
frame with a C-terminal HA epitope followed by the ADH1 terminator in pRS316 
under GAL1 promoter control.   
pYHB61 pRS316-GAL-HA-PRK1I116A; HA-tagged PRK1I116A under GAL1 promoter  
control in pRS316. 
pYHB111 pRS316-GAL-HA-PRK1Q207A; HA-tagged PRK1 Q207A under GAL1 promoter  
control in pRS316. 
pYHB107 pRS316-GAL-AKL1c-HA; The DNA coding region for AKL1 [1-1108 a.a.] in 
frame with a C-terminal HA epitope followed by the ADH1 terminator in pRS316 
under GAL1 promoter control.   
pYHB173 pRS316-GAL-AKL1-KD-c-HA; The DNA coding region for AKL1 [1-1108 a.a.] 
in frame with a C-terminal HA epitope followed by the ADH1 terminator in 
pRS316 under GAL1 promoter control. 
pYHB108 pRS316-GAL-AKL1K78Ac-HA; K78A mutation was introduced to create kinase-
dead version of pYHB107. 
pYHB174 pRS316-GAL-AKL1K78A-KD-c-HA; K78A mutation was introduced to create 
kinase-dead version of pYHB173. 
* The numbers in bracket indicate the amino acid residues [a.a.] included in the construct. 
* Plasmids denoted by pYHT, pYGS, pNSP and pYXW were from laboratory collection. Those 
denoted by pHB were created during this thesis work.  
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2.5     Yeast manipulations 
           Yeast genetic techniques were performed according to standard methods 
described in Rose el al (Rose et al., 1990). 
 
2.5.A    Gene disruption and integration 
Gene disruptions were performed by the one-step gene replacement method 
(Rothstein, 1991). Gene deletions in YMC474, YMC477, YMC486, and YMC487 
were created by integrating a HIS3, TRP1, or S. pombe HIS5 selection cassette to 
replace chromosomal loci. All deletion strains were confirmed by whole cell PCR 
analysis (Huxley et al., 1990).  
To obtain YMC446 [scd5-1], YMC448, and YMC449, plasmids pSCD5PBM2Δc, 
pSCD5c-HA, and pSCD5AAAc-HA were linearized within the SCD5 gene by BclI 
digestion and integrated into W303-1B, respectively. The integration was confirmed 
by PCR and sequencing analysis. YMC447 [prk1Δ scd5-1] was a progeny of a diploid 
made of a cross between YMC427 and YMC446. All integration strains were 
confirmed by whole cell PCR analysis. Cross of YMC446 with YMC422 containing 
pPAN1-316, YMC446 with YMC474 containing pEND3-316, YMC486 with 
YMC487 and DDY3063 (Kaksonen et al., 2005) with W303-1A followed by 
sporulation and dissection produced YMC472, YMC475 and YMC488, respectively. 
YMC481, YMC483, YMC489, and YMC491 were generated by integrating 
linearized pGLC7c-HA-305, pPAN1c-Myc-304, pSCD5PBM2Δ-HA-305, and pSCD5c-
Myc-304 into wild-type cells, respectively. The same strategy was used for the 
integration of pSCD5c-HA-305, pPAN1c-Myc-306, pGLC7T152Kc-HA-305, pGLC7n-
td-306, pGLC7n-ntd-306, pPRK1c-GFP-305 and pPAN1c-CFP-304 into respective 
strains. The C-terminal GFP-fused SCD5 in YMC496 and YMC498 was generated by 
the PCR-targeting method as described (Wach et al., 1997). 
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2.5.B     Two-hybrid assays 
             The MATCHMAKER system [Clontech Laboratories, USA] was used in 
two-hybrid analysis. DNA fragments of PAN1 or SCD5 and SCD5, GLC7 or END3 
were fused in frame to the GAL4 activation domain of pGADT7 and the DNA binding 
domain of pGBTT7 respectively, as indicated in Table 2. Plasmids were 
cotransformed into the yeast strain SFY526 and β-galactosidase activities were 
measured in at least three different isolates of each transformation. The β-
galactosidase assay was performed as described in the product protocol. Briefly, 1 ml 
of overnight culture in SC liquid medium lacking tryptophan and leucine was 
inoculated into 4 ml of YPD liquid medium and grown at 30°C till the OD600 was 
about 0.5 to 1.0. Cells in 1.5 ml of the culture were collected by centrifugation 
[performed in triplicates], washed with water, and resuspended in 300 μl of Z buffer 
[60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4]. 100 μl of the 
suspension [or Z buffer alone as a control] was transferred to fresh microfuge tubes 
and frozen in liquid nitrogen to break the cells. 700 μl of Z buffer containing 0.3% β-
mercaptoethanol was then added to the tubes, and the reaction was started by adding 
160 μl of 4 mg/ml ONPG [made in Z buffer]. After the appearance of yellow colour, 
the reaction was terminated by adding 400 μl of 1 M Na2CO3. The tubes were then 
centrifuged for 10 min at maximum speed to pellet the cell debris and the supernatant 
was measured at the absorbance of 420 nm relative to the control. The β-galactosidase 
activity [Miller units] was calculated as follows: 
                    β-galactosidase units = 1000 x OD420 / [0.5 x t x OD600] 
                      Where, t = time [in min] for yellow colour to develop 
                          OD600 = absorbance at 600 nm of 1 ml of culture 
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2.5.C    Endocytosis assays 
The lucifer yellow [LY] uptake assay was performed as described previously 
(Dulic et al., 1991) with minor modifications. Cells were grown at 25 οC in YEPD to 
early log phase, and cultures were kept at 25οC or pre-shifted to 37 oC for 15 min 
before addition of Lucifer Yellow CH dilithium [Sigma] to 5 mg/ml. After incubation 
for 2 h at 25°C or 37°C, cells were collected and washed five times with PBS 
containing 10 mM sodium azide and 50 mM sodium fluoride, followed by suspension 
in Vectashield mounting medium [Vector Laboratories, Burlingame, CA] and 
observation by fluorescein isothiocyanate [FITC] and Nomarski optics with a Leica 
DMAXA microscope equipped with a Hamamatsu C4742-98 digital camera.            
To observe the internalization of Ste3p, cells containing pGAL-STE3-EGFP 
were grown at 25 οC in dropout medium supplemented with raffinose to early log 
phase followed by addition of galactose to 2%. After incubation at 25 οC for 45 min, 
cultures were kept at 25 οC or pre-shifted to 37 οC for 15 min before addition of 
glucose to 3%. Samples were taken at 15- min intervals at 25 οC or 37 οC immediately 
upon addition of glucose, washed three times with PBS containing 10 mM sodium 
azide and 50 mM sodium fluoride, suspended in Vectashield mounting medium, and 
visualized with the Leica DMAXA microscope. 
 
2.6     Microscope imaging 
2.6.A   Rhodamine-phalloidin staining of actin filaments 
Staining of actin filaments with rhodamine-phalloidin [Molecular Probes, 
Eugene, OR] was performed as described previously (Adams & Pringle, 1991) with 
minor modifications. Cells were grown at 25 οC in YEPD to early log phase and then 
kept at 25 οC or shifted to 37 οC. After incubation for 4 h, cells were colleted and 
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suspended in fixation solution [3.7 % formaldehyde, 100 mM KH2PO4, 100 mM 
K2HPO4] for 15 min. Cells were then washed two times with PBS and resuspended in 
PBS containing 0.1% Triton X-100 for 15 min. After washing again with PBS for two 
times, cells were incubated with PBS containing rhodamine-phalloidin [1:100] at 
25 οC for 30 min. Cells were finally washed with PBS for four times and suspended in 
Vectashield mounting medium before visualization with the Leica DMAXA 
microscope. 
 
2.6.B    Live cell imaging 
Yeast cells expressing GFP and/or CFP tagged proteins were allowed to grow 
to early log phase at 30°C. Cells were harvested, resuspended in SC media, and 
adhered to the surface of an agarose [2 %] coated glass slide, which was covered with 
a coverslip and sealed with vaseline. Fluorescence microscopy was performed using a 
Zeiss Axiovert 200 M microscope equipped with a Coolsnap HQ camera [Roper 
Scientific, Tucson, AZ]. All imaging was done by keeping the slide within a closed 
chamber at 30°C.  Images were acquired continuously at 1 frame/ 2-5 s, depending on 
the signal intensity, with motorized GFP and CFP filters. The CCD camera and the 
filter wheel were controlled by MetaMorph software [Universal Imaging, 
Downingtown, PA].  To determine the patch lifetime of each protein, more than 30 
patches were visually analyzed for their time points of appearance and disappearance.   
 
2.7     Biochemical assays 
2.7.A   Yeast extract preparation 
Yeast strains were grown under selective conditions to mid-log phase [OD600 
= 0.9 to 1.2]. Cells were harvested, washed once with Stopmix [0.9% NaCl, 1 mM 
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NaN3, 10 mM EDTA, 50mM NaF] and resuspended in 200 μl of ice-cold lysis buffer 
[1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl [pH7.2] 
with the additional of 1 mM PMSF, phosphatase inhibitor cocktail [10 µM of sodium 
fluoride, 2 mM of sodium orthovanadate, 2 mM of sodium pyrophosphate, 6 mM of 
β-glycerophosphate] and protease cocktail [tablets from Roche Diagnostics, 
Mannheum, Germany]. Cells were then lysed by vortexing with 500-μm-diameter 
acid-washed glass beads [Sigma] at 4°C. After centrifugation at high speed for 10 
min, the supernatant was transferred to a new tube and the protein concentration was 
determined using the Bradford Protein Assay reagent [Bio-Rad].  
 
2.7.B    Immunoprecipitation, TCA precipitation and Western blot 
 
To immunoprecipitate epitope-tagged proteins, either beads-conjugated anti-
HA or anti-Myc polyclonal antibodies were used. The beads were washed 5 times 
with RIPA buffer [1% Nonidet P-40, 150 mM NaCl, 0.5% sodium deoxycholate, 50 
mM Tris-HCI [pH7.2], 5 mM EDTA, 1 mM sodium orthovanadate], and the bound 
immuno-complexes were released by boiling in SDS-loading buffer for 8 min. After 
centrifugation, samples were loaded on SDS-polyacrylamide gel for electrophoresis 
and the separated proteins were electroblotted onto Immobilon PVDF membrane 
[Millipore]. The HA-tagged and Myc-tagged proteins were detected using mouse anti-
HA 12CA5 and mouse anti-Myc 9E10 antibodies, respectively, followed by HRP-
conjugated sheep anti-mouse antibody [Amersham]. For immunoblotting of 
phosphorylated proteins, a rabbit anti-phosphothreonine antibody [Zymed, San 
Francisco, CA] was used.   
To analyze the gel mobility change of Scd5p upon PRK1 overexpression, 
yeast cells [YMC448 and YMC449] containing various plasmids [pRS316, pGAL-
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PRK1, and pGAL-PRK1D158Y] were grown at 30°C to log phase followed by addition 
of galactose to 2%. After incubation for 5 h, 4 OD600 of cells were collected and 
washed once with ice-cold water. The cells were suspended in 400 μl of lysis buffer 
[925 mM NaOH, 3.75% β-mercaptoethanol] and incubated on ice for 20 min. Cell 
lysates were mixed with equal volume of 50% TCA and incubated on ice for 10 min, 
followed by centrifugation at high speed for 5 min. The pellets were washed once 
with ice-cold phosphate-buffered saline [PBS] and dissolved in 100 μl of protein 
loading buffer. 10 μl of 1 M Tris-HCl [pH 8.0] was finally added to each sample for 
pH adjustment. 
 
2.7.C    In vitro protein-binding assay
To demonstrate the direct association between Scd5p and Pan1p, His-tagged 
Scd5 and GST-LR2-Pan1 were prepared for in vitro binding assay. First, various 
fragments of Scd5p [N1, N2 and C] were cloned into vector pET-32a [Novagen] and 
expressed in E. coli strain BL21. These [His]6-tagged fusion proteins were then 
yielded by incubating the bacterial cell lysates with Ni-NTA agarose beads 
[QIAGEN]. GST-LR2 or GST as binding control were expressed in E. coli strain 
DH5α and purified as described previously (Zeng & Cai, 1999). For the binding assay, 
the beads-immobilized [His]6-Scd5 fragments were incubated with GST-LR2 or GST. 
The precipitates were washed 3 times with wash buffer [200 mM NaCl, 20 mM 
HEPES with pH 7.3, 0.1 % Triton X-100, 1 mM DTT] and separated by gel 
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2.7.D    In vitro kinase and phosphatase assays 
Expression and purification of GST-fusion proteins followed the published 
procedure (Zeng & Cai, 1999). In vitro kinase assays using radioactive ATP were 
performed as described (Zeng & Cai, 1999). To measure the relative phosphorylation 
intensity, the images of substrate protein bands were taken with Nikon COOLPIX995 
digital camera and imported into the Multi-Analysis software [Bio-Rad, U.S.] for 
normalization. The bands were then excised from the dried gel and transferred to 
scintillation counting vials. 5 ml of Ecoscint-scintillation liquid [National Diagnostics, 
U.K.] was dispensed into each vial and counted with LKB 1219 RackBeta Automatic 
Liquid Scintillation Counter [Wallac Oy, Finland]. 
Assays using cold ATP were similar with slight modifications. Bead-
conjugated anti-HA antibody was used to immunoprecipitate HA-Prk1p. GST-fusion 
proteins were mixed with the immunoprecipitated kinase, 60 µl of HBII buffer, 10 µl 
of 100 mM ATP, and 10 µl of 250 mM MOPS in a total volume of 200 µl and 
incubated at 25°C for 3 h, followed by gel electrophoresis and sequential 
immunoblotting with anti-GST and anti-PThr antibodies. With the use of VIVASPIN 
500 column [Vivascience, Hannover, Germany], GST-fusion proteins were washed 
and changed into either binding buffer [100 mM NaCl, 20 mM HEPES with pH 7.3, 
0.1% Triton X-100, 1 mM DTT] for in vitro binding assays or H2O for protein 
phosphatase assays.  
For protein phosphatase assays, yeast extracts containing endogenously 
expressed Glc7-HA were prepared with phosphatase inhibitor-free lysis buffer [1% 
Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl [pH7.2], 1 mM 
PMSF] supplemented with protease inhibitors. Glc7-HA was immunoprecipitated and 
washed with RIPA buffer. The immunoprecipitates, with or without the preincubation 
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with 1 µl of PP1 inhibitor I-2 [New England Biolabs, Ipswich, MA] at 25°C for 15 
min, were mixed with phosphorylated GST-fusion proteins and 10 µl of 10X PP1 
buffer [New England Biolabs] in a total volume of 100 µl. The mixture was incubated 
at 37°C and 20 µl of supernatant was taken at each time point in 20 min intervals. 
Samples were then subjected to gel electrophoresis and sequential immunoblotting 
with anti-GST and anti-PThr antibodies.     
 
2.8     Structural modeling 
A three-dimensional model of the kinase domain [residues 23 to 298] of Prk1p 
[NCBI accession number NP_012171] was generated from the SWISSMODEL [Guex 
and Peitsch, 1997] automated protein structure homology-modeling server 
[http://www.expasy.org/swissmod/SWISS-MODEL.html]. A total of 89 templates 
from different serine/threonine and tyrosine kinases with sequence identity ranging 
from 25 to 40% were used. Subsequent modeling employed Sybyl 6.8 [Tripos Inc., St 
Louis, MO] and all energy calculations invoked the Kollman force field. Holding the 
backbone constant, the model of Prk1p was minimized, followed by an alignment 
with the crystal structure of a serine/threonine kinase [2PHK] possessing a bound 
peptide. The bound peptide was extracted into our model and substituted to 
PLTAQKTGF, the LxxQxTG motif of Pan1p present in the in vitro substrate R15. 
Essential interactions necessary for phosphotransfer were modeled according to 
reported observations (Madhusudan et al., 1994). The peptide’s P0 [Thr] residue was 
placed in close proximity to the catalytic residue Asp158 and the peptide-anchoring 
residue Lys160. Peptide residues P-2 [Gln] to P0 [Thr] together with kinase residues 
within 8Å proximity were energetically refined. The carboxyl group of Asp158 was 
measured to be ~1.7Å from the hydroxyl hydrogen of P0 [Thr]. Gln207 was found to 
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establish a critical H-bond [~1.8Å] with P-2 [Gln]. 12 pockets were identified on the 
surface of the kinase by SiteID in Sybyl. The closest pocket to P-2 [Gln] is 
hydrophobic, being lined by residues Ile117, Met120 and Ile238. P-5 [Leu] was 
docked into this pocket using DOCK from sybyl6.8. Thereafter, the link between P-5 
[Leu] and P-2 [Gln] was constructed and further minimization was performed. A 
conformational search was performed to determine the optimal side chain 
conformation of P-5 in the pocket. Finally, a MOLCAD surface was created to 
display the docked conformation with the use of Sybyl6.8. 
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3.1   Introduction 
The Prk1p family of kinases have been shown to play a critical role in coat 
disassembly in yeast endocytosis (Sekiya-Kawasaki et al., 2003; Toshima et al., 2005). 
PRK1 was originally identified in a genetic screen for suppressors of pan1-4 TS 
phenotype (Zeng & Cai, 1999). It was found that prk1Δ is able to rectify the abnormal 
actin cytoskeleton and defective endocytosis observed in pan1-4 mutant. Examination 
of Prk1p protein subcellular localization revealed colocalization with actin patches 
(Cope et al., 1999; Zeng & Cai, 1999), suggesting that Prk1p is functionally related to 
actin cytoskeleton and endocytosis. Since Prk1p sequence contains numerous 
elements conserved in serine-threonine kinases, this raises the possibility that Prk1p 
may regulate Pan1p activity via phosphorylation. In vitro kinase assays were 
attempted on various truncations of Pan1p, leading to the finding that Prk1p targets 
LxxQxTG motifs (Zeng & Cai, 1999). Subsequently, Prk1p was shown to 
phosphorylate the LxxQxTG-containing protein Sla1p (Zeng et al., 2001), a 
component of the trimeric endocytic complex Pan1p/Sla1p/End3p (Tang et al., 2000). 
The next obvious question is how the phosphorylation by Prk1p affects the functions 
of Pan1p and Sla1p. GST pull-down and column fractionation experiments showed 
that the phosphorylation of either Pan1p or Sla1p disrupts the interaction between the 
two. Hyperphosphorylation of Pan1p also diminishes its affinity for End3p. In 
summary, Prk1p phosphorylation promotes disassembly of the trimeric 
Pan1p/Sla1p/End3p complex (Zeng et al., 2001).  
To better understand mechanistically how phosphorylation of Pan1p and Sla1p 
by Prk1p can affect protein complex stability, we intended to determine all the 
possible Prk1p target sites located within the functional domains in Pan1p and Sla1p. 





comprehensively (Zeng & Cai, 1999), we started by testing whether LxxQxTG is the 
sole target sequence for Prk1p. 
 
3.2 Results 
3.2.A   Hydrophobic residues at P-5 are required for Prk1p recognition 
For the convenience of description, the threonine in the LxxQxTG motif was 
given a position number P0, and the residues upstream or downstream of P0 were 
designated as P-n or P+n, respectively [Fig. 3-2B]. Zeng and colleagues have 
confirmed that the glycine residue at P+1 in LxxQxTG is strictly required for proper 
phosphorylation (Zeng & Cai, 1999). This substrate was derived from R15, a GST-
fused Pan1p fragment [amino acids 564 – 846] which contained a single LxxQxTG 
motif and had been used as a standard substrate for Prk1p in the previous in vitro 
kinase assays (Zeng & Cai, 1999).  
We first asked whether the leucine residue at P-5 position is important. 
Interestingly, multiple additional motifs of QxTG, in which the P-5 position is other 
residues than L, are also present within Pan1p and Sla1p as shown in Fig. 3-1. These 
multiple QxTG motifs may represent additional patterns of Prk1p recognition 
sequence. To investigate this possibility, the L residue of R15-WT at P-5 was mutated 
to each of the P-5 variations found in Pan1p and Sla1p, namely, I, M, P, V, T, A, S, 
and N. In vitro kinase assays showed that three of these residues, I, M and V, were 
able to confer Prk1p phosphorylation. As these residues are all hydrophobic, two 
additional hydrophobic residues, F and W, were also tested for their ability to support 
Prk1p phosphorylation. As shown in Fig. 3-2B, neither R15-L/F nor R15-L/W could 











Distribution of QxTG motifs in Pan1p [A] and Sla1p [B]. Red ovals represent 









































Analysis of sequence requirement at P-5 for Prk1p recognition.  
A.  Western blotting of Prk1p and its kinase-dead mutant Prk1D158Yp (Zeng & Cai, 
1999). The HA-tagged proteins were immunoprecipitated from equal amounts of 
cell extracts with the rabbit anti-HA antibody and analyzed on immunoblots. 
B.  Phosphorylation of the [L/I/V/M]xxQxTG motifs by Prk1p. GST-fusion proteins 
of R15-WT and its mutants bearing various substitutions at P-5 as indicated were 
prepared and subject to in vitro kinase assay. Phosphorylation results were shown 
as autoradiography and the substrates were visualized by the Coomassie-blue 
staining. 
C.  Comparison of phosphorylation efficiency of the [L/I/V/M/F/P/W/A]xxQxTG 
motifs. The bands of the substrates were excised from the gel for scintillation 
counting after autoradiography and the results were normalized against the 
amounts of the substrates. Phosphorylation efficiencies of each motif were 









residues to P-5 did not result in identification of additional Prk1p recognition patterns 
[data not shown].  
Although all the P-5 residues suitable for Prk1p phosphorylation were 
hydrophobic, they differed in phosphorylation efficiency [Fig. 3-2C]. Among them, L 
is most optimal. This is consistent with the fact that LxxQxTG is present most 
frequently in the known Prk1p substrates, Pan1p and Sla1p (Zeng et al., 2001). 
Following L, in a descending order, are I, V and M, with phosphorylation efficiencies 
of 36%, 15% and 13%, respectively, of that of L.  
In addition, introduction of an L into other positions [P-6, P-4 and P-3] of 
R15-L/A failed to confer Prk1p phosphorylation [Fig. 3-3, lanes 2, 4 and 5]. These 
results indicate that there is a stringent requirement for leucine at P-5, but not other 
















The requirement for leucine at P-5 for Prk1p recognition.  
GST-fusion proteins of R15-WT and its mutants were prepared and subjected to in 
vitro kinase assay. R15-L/A [lane 1] carried an L to A mutation at P-5, whereas 
mutants in lanes 2, 4, and 5 had an additional mutation that introduced L into 







3.2.B   Identification of N, T and S as additional P-2 residues  
Using R15 variants as substrates, we identified [L/I/V/M]xxQxTG motifs as 
new phosphorylation sites of Prk1p. To verify this finding, we chose Yap1801p and 
Ent1p, two yeast proteins that contain some of these newly identified motifs, to test 
their ability to act as substrates of Prk1p in vitro. Yap1801p was originally identified 
as one of the yeast homologs of the mammalian clathrin assembly protein AP180 
from a yeast two-hybrid screen using the Eps15-homology [EH] domains of Pan1p as 
a bait (Wendland & Emr, 1998). The same screen also identified a pair of yeast epsins, 
Ent1p and Ent2p (Wendland et al., 1999). Yap1801p contains one [VxxQxT413G] 
while Ent1p has two [IxxQxT395G and LxxQxT415G] Prk1p recognition motifs in their 
Pan1p EH domain-binding regions [Fig. 3.4A]. Recently, Ent1p has been shown to 
exhibit Prk1p-dependent phosphorylation on its [L/I]xxQxTG motifs in vivo (Watson 
et al., 2001). Nevertheless, it is of interest to test whether it can be directly 
phosphorylated by Prk1p in vitro. 
As expected, a GST-fusion protein containing the VxxQxTG motif of 
Yap1801p [Yap1801WT] was efficiently phosphorylated by Prk1p [Fig. 3-4B, lane 1]. 
Surprisingly, however, when the T residue within VxxQxTG was mutated to A 
[T413A], the resulting protein Yap1801T/A could still be phosphorylated by Prk1p 
[Fig. 3-4B, lane 2]. Similar observation was also made with Ent1p. While GST-fusion 
proteins containing both, or either one, of the [L/I]xxQxTG motifs of Ent1p could be 
efficiently phosphorylated by Prk1p [Fig. 3-4B, lanes 3-5], disruption of both motifs 
by site-directed mutagenesis [T395A and T415A] failed to abolish the Prk1p-
dependent phosphorylation [Fig. 3-4B, lane 6]. These results indicate that there must 























Identification of N, T and S as additional P-2 residues for Prk1p recognition. 
A. Schematic diagrams of Yap1801p and Ent1p showing the distribution of Prk1p 
phosphorylation sites. The QxTG-containing [●] and [N/T/S]xTG-containing [▲] 
motifs are found in the Pan1p EH domain-binding regions [gray boxes] of each 
protein, in the vicinity of the NPF motifs [solid boxes]. The bars beneath each of 
the diagrams indicate the region from each protein expressed as GST-fusion 
proteins.  
B/C. Phosphorylation of Yap1801p, Ent1p and their mutants by Prk1p. The substrates 
used in each reaction are as indicated. Substrates in C are labeled with the 
identities at P0 of the motifs arranged in a sequential order. For example, 
Yap1801AAT [C, lane 4] is a mutant carrying the T to A mutations in the first two 
of the three motifs. Phosphorylation results were shown as autoradiography and 







Upon a closer examination of the sequences of Yap1801p and Ent1p, several 
motifs approximately resembling the phosphorylation targets of Prk1p were spotted. 
They were LxxTxT427G and VxxSxT453G on Yap1801p, and LxxNxT346G, 
LxxTxT366G, and VxxTxT427G on Ent1p [Fig. 3-4A]. These motifs differ in that they 
have residues N, T, and S rather than Q at the P-2 position. Two observations 
suggested that these motifs may also be phosphorylation sites of Prk1p. First, these 
motifs are clustered within a short region in both Yap1801p and Ent1p known to be 
involved in protein-protein interactions, i.e., the Pan1p EH domain-binding region 
(Wendland & Emr, 1998; Wendland et al., 1999), similar to the distribution of the 
LxxQxTG motifs in Pan1p and Sla1p. Second, several such motifs were also found in 
Pan1p [LxxTxT241G, MxxNxT464G and LxxTxT944G] and Sla1p [IxxNxT730G and 
IxxSxT923G]. Indeed, as shown in Fig. 3-4C, both VxxQxT413G and LxxTxT427G 
motifs from Yap1801p could be phosphorylated by Prk1p [Fig. 3-4C, lanes 2 and 3]. 
There was no detectable phosphorylation on the VxxSxT453G motif [Fig. 3-4C, lane 4], 
although scintillation counting revealed a reading two-fold higher than that of the 
background [data not shown]. After all these sites were mutated, the phosphorylation 
on Yap1801p by Prk1p was completely eliminated [Fig. 3-4C, lane 1]. Similarly, any 
one of these motifs from Ent1p was able to support phosphorylation by Prk1p, albeit 
to varying degrees [Fig. 3-4C, lanes 6-10], whereas the mutant with all the motifs 
mutated showed no Prk1p phosphorylation [Fig. 3-4C, lane 5]. Then we concluded 
that N, T and S are the additional P-2 residues in the Prk1p recognition motif. 
Combining all the sequence requirements at P-2 and P-5, the Prk1p 
phosphorylation motif is now consolidated to be [L/I/V/M]xx[Q/N/T/S]xTG. Again 
using R15 as a template, we generated a series of mutants to compare their efficiency 





of LxxQxTG shown in Fig. 3-2B. Fig. 3-5A showed the in vitro kinase assay result of 
the test on the [L/I/M/V]xxNxTG motifs. It is clear that different combinations gave 
rise to different phosphorylation efficiencies [Fig. 3-5A, lanes 1-4]. Similar tests were 
also performed on [L/I/M/V]xxTxTG, and [L/I/M/V]xxSxTG, as shown in Fig. 3-5B 
and Fig. 3-5C, respectively. Finally, these results were compared in Fig. 3-5D. 
Consistent with our result obtained with native substrate, namely, Yap1801AAT [Fig. 



























Comparison of phosphorylation efficiency of the [L/I/V/M]xx[Q/N/T/S]xTG 
motifs.  
A. Phosphorylation of the [L/I/V/M]xxNxTG motifs by Prk1p.  
B. Phosphorylation of the [L/I/V/M]xxTxTG motifs by Prk1p.  
C. Phosphorylation of the [L/I/V/M]xxSxTG motifs by Prk1p. The substrates used in 
lanes 1 to 4 are labeled to show their residue identities at P-5 and P-2. For 
example, R15-LN [A, lane 1] represents the motif of LxxNxTG. The substrates 
used in the lanes 5 are the negative controls and labeled with residue identities at 
P-2 and P0, e.g., R15-NA [A, lane 5] represents the motif of LxxNxAG.  
D. Comparison of Prk1p phosphorylation efficiencies on the [L/I/V/M]xx [Q/N/T/S]x
TG motifs. The phosphorylation results were measured by scintillation counting 








3.2.C   Prk1p targets threonine but not serine residues 
Many eukaryotic serine/threonine kinases are able to phosphorylate either S or 
T residue in specific context (Kemp & Pearson, 1990). Interestingly, there exists one 
motif [VxxQxS524G] that fits the core recognition sequence illustrated earlier except 
with the substitution of T [P0] to S in Pan1p. Whether Prk1p targets serine was yet to 
be tested.  In the control experiments, the immunoprecipitated HA-Prk1p [Fig. 3-2A, 
lane 3] was able to phosphorylate the GST-fusion protein R15-WT [Fig. 3-6, lane 3], 
while the anti-HA immunoprecipitates from cells containing either untagged Prk1p 
[Fig. 3-2A, lane 1], or HA-tagged kinase-dead mutant of Prk1p [HA-Prk1D158Yp; Fig. 
3-2A, lane 2], failed to phosphorylate the same protein [Fig. 3-6, lanes 1 and 2]. Prk1p, 
on the other hand, was unable to phosphorylate R15-T/S, an R15 variant with a T to S 
mutation at P0 [Fig. 3-6, lane 4]. This result confirmed that the Prk1p phosphorylation 










Prk1p was unable to phosphorylate LxxQxSG.  
The immunoprecipitated proteins and substrates used in each reaction are as indicated. 
Phosphorylation results were shown as autoradiography and the input substrates were 







3.2.D   Prk1p tolerates alterations in amino acids at P-2 
Thus far, we have established a general phosphorylation motif for Prk1p as 
[L/I/V/M]xx[Q/N/T/S]xTG. Previous work (Zeng & Cai, 1999) and our results have 
confirmed that small hydrophobic residues are strictly required at P-5; threonine at P0 
and glycine being the smallest amino acid sterically at P+1 is absolutely important. 
What remains unclear is whether the requirement for [Q/N/T/S] at P-2 is stringent as 
in the case of P-5.  
Previously additional P-5 residues supporting phosphorylation were identified 
when testing all QxTG motifs regardless of the identity of P-5 residue. A similar 
strategy was employed here. To identify additional positive elements at P-2 position, 
we first aligned all the [L/I/V/M]xxxxTG motifs present in Pan1p [Fig. 3-7A] and 
Sla1p [Fig. 3-7B]. Apparently among the 19 motifs in Pan1p, 16 of them have Q and 
2 of them have T and 1 of N at P-2. In the case of Sla1p, the P-2 residue variations are 
much greater. There are 10 repeats that conform to the characterized motif with Q [8], 
N [1] and S [1] residues at the P-2 [The number in the brackets after each amino acid 
denotes the occurrences]. Intriguingly, additional 11 repeats are spotted with 
hydrophobic amino acids at P-2, including F [5], L [2], A [2], M [1] and V [1]. We 
first tested whether these residues at P-2 support Prk1p phosphorylation by in vitro 
kinase assays. Mutations to the exact P-5 and P-2 residues of the 11 uncharacterized 
repeats [Fig. 3-8A] were introduced into R15-WT. Shown in Fig. 3-8B-C the results 
demonstrate that Prk1p is able to recognize motifs with hydrophobic residues at P-2 
with varying preferences.  
We next asked whether acidic residues at P-2 can confer Prk1p 
phosphorylation as well. Q to D mutation was introduced to R15 and in vitro kinase 

























Distribution of [L/I/V/M]xxxxTG motifs in Pan1p [A] and Sla1p [B]. Red ovals 
represent [L/I/V/M]xx[Q/N/T/S]xTG repeats. Black ovals are [L/I/V/M]xxxxTG 
motifs where P-2 residues are NOT Q/N/T/S.  
 
 




































































Hydrophobic residues at P-2 support Prk1p phosphorylation. 
A. The lane arrangement. R15 mutants correspond to the variants occurring in Sla1p 
sequentially.  
B. The three MxxFxTG repeats located at the very C-terminus were represented in 
one lane [Lane 10]. Phosphorylation results were shown as autoradiography and 
the input substrates were visualized by Coomassie-blue staining.  
C.  Comparison of Prk1p phosphorylation efficiencies on the Sla1p-specific motifs. 
The phosphorylation results were measured by scintillation counting and 










phosphorylation intensity as Q to A mutation, indicating that D present at P-2 does 
not interfere with the kinase recognition [Fig. 3-9]. We did not determine whether the 
presence of basic amino acids at P-2 affects Prk1p phosphorylation efficiency, 
because no [L/I/V/M/]xx[K/R/H]xTG repeat is found in Pan1p and Sla1p.  
All these data indicate that Prk1p tolerates more variations in P-2 amino acid 
identities in contrast to the absolute requirement for small hydrophobic groups at P-5. 











Aspartic acid at P-2 does not interfere with Prk1p recognition.   
The immunoprecipitated proteins and substrates used in each reaction are as indicated. 
Phosphorylation results were shown as autoradiography and the input substrates were 
visualized by Coomassie-blue staining.  
 
 
3.2.E   Determining the substrate specificities of Prk1p analogues - Ark1p and 
Akl1p 
 
The family of actin-regulating kinases in budding yeast comprises three 
members: Ark1p, Prk1p and the lesser-studied Akl1p(Smythe & Ayscough, 2003). As 
shown in Fig. 3-10, the kinase domain of Prk1p shares over 70% of sequence 
homology with that of Ark1p. This agrees with the finding that Ark1p also plays an 
important role in regulating actin cytoskeleton and endocytosis (Cope et al., 1999). 







Homology among the kinase domains of the Prk1 family kinases of budding 
yeast and the human orthologue adaptor-associated kinase AAK1.  
A.  Multiple alignment output of AlignX [Vector NTI Suite, InforMax] of kinase 
domains of various related kinases.  







less than 50% homologous to that of Prk1p. Substrate specificities were first 
investigated by performing in vitro kinase assays with immunoprecipitated HA-
tagged Ark1p and Akl1p.  
GST fusions with the first long repeat [LR1] spanning the N-terminal region 
of EH1 and the second long repeat [LR2] covering the sequence between the 2 EH 
domains of Pan1p [Fig. 3-11B] were used as substrate. In contrast to Prk1p, Ark1p 
did not phosphorylate either of the long repeats containing multiple Prk1p target sites 
[Fig. 3-11C]. Surprisingly, Akl1p was able to phosphorylate LR1 and LR2 as 
efficiently as Prk1p under the same assay conditions [data not shown]. To further 
characterize Akl1p’s substrate specificity, R15 with various P-2 mutants were used as 
substrates for in vitro kinase assay. As shown in Fig. 3-12, the immunoprecipitated 
Prk1p-HA and Akl1p-HA [Fig. 3-12A] were able to phosphorylate the GST-fusion 
protein R15-WT [Fig. 3-12B, lane 1 and 7], while the anti-HA immunoprecipitates 
from cells containing the HA-tagged, kinase-dead mutant of Akl1p [Akl1K78Ap; Fig. 
3-12A] failed to phosphorylate the same protein [Fig. 3-12B, lane 8]. In the negative 
control [lane 6] in which the target threonine residue was mutated to alanine, no 
specific phosphorylation band as the arrow indicated was observed. Furthermore, 
Akl1p could also phosphorylate the P-2 variants of R15 [Fig. 3-12B, lane 2-5] to 
various degrees as observed for Prk1p [Fig. 3-5]. It’s noteworthy that kinase assays 
with Akl1p produced multiple bands in the autoradiography that are not specific to 
phosphorylation on the substrate [Fig. 3-12B, lanes 1-6]. Interestingly, these non-
specific phospho-bands were not observed with Akl1K78Ap, the kinase-dead mutant 
[lane 8], neither were they observed with Prk1p [lane 7]. The implication of this 





























Ark1p does not phosphorylate Pan1p motifs in LR1 and LR2. 
A. Western blot of HA-Prk1p and Ark1p-HA from total yeast lysates.  
B. LR1 contains 5 motifs preceding EH1. LR2 contains 13 motifs in between the 2 
EH domains. 
C. Lane 1 and 3 of the substrate input gel are GST-Pan1p-LR1; Lane 2 and 4 are 
GST-Pan1p-LR2. Phosphorylation results were shown as autoradiography and the 












Akl1p shares the same phosphorylation site preference with Prk1p. 
A. Western blotting of Prk1p, Akl1p and its kinase-dead mutant Akl1K78Ap. The HA-
tagged proteins were immunoprecipitated from equal amounts of cell extracts with 
the rabbit anti-HA antibody and analyzed on immunoblots. 
B. Phosphorylation of the Lxx[Q/N/T/S/A]xTG motifs by Akl1p. GST-fusion proteins 
of R15-WT [Lane 1, 7 and 8] and its mutants bearing various substitutions at P-2 
[Lane 2-5] and target threonine [Lane 6] as indicated were prepared and subjected 
to in vitro kinase assay. The arrow indicates the specific phosphorylation bands. 
Phosphorylation results were shown as autoradiography and the substrates were 








3.2.F    Structural modeling of the Prk1p kinase domain 
Thus far the minimal phosphorylation motif for Prk1p has been determined as 
[L/I/V/M]xxxxTG. Of particular interest, the kinase domain of Ark1p shares a 
significantly higher level of homology with that of Prk1p than Akl1p does based on 
primary sequence alignment [Fig. 3-10]. Surprisingly, it is Akl1p that more closely 
resembles the kinase specificity of Prk1p, suggesting that the three-dimensional [3D] 
structural features rather than primary sequence alone may be more important to 
dictate the enzymatic specificity of a kinase. To gain some insights on the structural 
basis of Prk1p’s function, a homology-based 3D model of the Prk1p kinase domain 
[residues 23 to 298] was generated as described in Chapter 2, as the X-ray crystal 
structures of Prk1p or other members of this family have not been resolved.  
Based on this model, the Prk1p kinase domain comprises two main portions: 
an N-terminal lobe and a C-terminal lobe [Fig. 3-13A]. The N-terminal lobe [residues 
23 to 110] consists of five anti-parallel β strands [β1 to β5] and one α helix [helix C], 
and is responsible for binding ATP through a glycine loop located between β1 and β2. 
The C-terminal lobe [residues 111 to 298] consists of a four-helix bundle [helices D, 
E, F and H] that is flanked by two smaller helices and two short anti-parallel β sheets. 
The catalytic loop with the conserved catalytic Asp158 residue and the activation 
segment [residues 176 to 212] are both located in this lobe. Using the sequence of 
PLTAQKTG [the LxxQxTG motif present in the in vitro substrate R15] as the 
substrate peptide, a structural model of the kinase-substrate complex was further 
constructed [Fig. 3-13B]. In the docked state, the substrate peptide binds in an 
extended conformation across the kinase catalytic site, contacting only the C-terminal 
lobe of the kinase domain [Fig. 3-13B]. Key residues involved in docking the 







Interactions between Prk1p and its recognition motifs depicted by homology 
based modeling.  
A. Two views of the Prk1p kinase domain. The left view has ribbons and loops 
colored by B-factor. Blue indicates regions with high degree of conservation and 
red low conservation. The major secondary structures such as β strand and α
helix are also labeled. The right view highlights the important features of the 
kinase domain. The light green region represents the N-terminal lobe and the light 
blue region the C-terminal lobe. The Glycine loop is in dark blue. The C-terminal 
lobe includes an activation segment in orange, four helices [D, E, F and H] in dark 
green, and the catalytic residue Asp158 in dark blue. A P-5 binding pocket formed 






B. A general view of the kinase domain of Prk1p with a substrate peptide 
[PLTAQKTG] bound. The kinase domain is visualized with a MOLCAD surface 
colored by Lipophilic Potential. The positions of the activation segment, the ATP-
binding pocket, the catalytic residue Asp158, and the P-5 binding pocket are as 
indicated.  
C. Schematic representation of the molecular interactions between Prk1p and its 
substrate peptide. The substrate peptide colored in black is shown together with 
the kinase residues essential for the interaction. Amino acids involved in docking 
the P-2 residue are colored in blue and residues making up the P-5 binding pocket 
are colored in yellow. The dashed lines represent the hydrogen bonds between the 
carboxyl side chain of Asp158 and the hydroxyl group of P0, the amine side chain 
of Lys160 and the backbone carbonyl group of P-1, and the amide group of 
Gln207 and the amine or hydroxyl group of P-2, respectively. 
 
binding pocket is made up of three residues-Ile117, Met120 and Ile238. [Fig. 3-13C]. 
Studies on the substrate-kinase complex model revealed four sets of essential 
interactions between Prk1p and the [L/I/V/M]xx[Q/N/T/S]xTG motif [Fig. 3-13C]. 
Among these interactions, three of them are the hydrogen bonds between the carboxyl 
side chain of Asp158 and the hydroxyl group of P0 residue T, the amine side chain of 
Lys160 and the backbone carboxyl group of P-1 residue, and the amine group of 
Gln207 and the amine group [Q and N] or the hydroxyl group [T and S] of the P-2 
residue [Fig. 3-13C, dashed lines]. The other interaction is the Van Der Waals force 
between the hydrophobic binding pocket and the P-5 hydrophobic residue [Fig. 3-
13C]. The interaction between the hydrophobic pocket of the kinase and the P-5 
residue of the substrate explains why only hydrophobic residues should be present at 
P-5. Among all the hydrophobic residues, i.e., A, I, L, M, F, P, W and V, only L, I, V 
and M are the suitable P-5 residues, because A would be too small and F too bulky to 
be well docked inside the pocket, whereas both P and W are not flexible enough to be 
compacted into the pocket due to their rigid structures.  
Next we asked: what is the structural basis for the relative preference of Prk1p 
for P-5 residue as L>I>V>M [Fig. 3-2C]. The kinase showed little recognition of F 





interaction of the P-5 residue with the hydrophobic binding pocket of Prk1p. L and 
four other mutations [I, V, M, F] were docked into the P-5 binding pocket. The 
individual residue energy of the P-5 residue was calculated in 3 different states: a 
docked state, a strained state and a relaxed state [Fig. 3-14A]. The strained state is 
when the residue’s side chain in the docked conformation but not within the binding 
pocket. The relaxed state describes the energy minimum state of the P-5 side chain. 
The energy transition between the relaxed to strained state [R to S transition, Fig. 3-
14B] corresponds to the energy barrier to binding of the P-5 into the pocket. A higher 
energy barrier indicates a lower reaction rate and vise versa. The transition between 
the strained to docked energies [S to D transition, Fig. 3-14B] are indicative of the 
stability of the docked P-5 residue in the pocket at equilibrium. The lower the S to D 
transition energy, the better the P-5 residue fits in the pocket. The reaction kinetics for 
the transition from an enzyme/ATP/substrate complex to an enzyme/ADP/phospho-
substrate complex has been demonstrated to be fast (Madhusudan et al., 1994). 
However the rate limiting step for substrate phosphorylation is the initial relaxed to 
strained energy [R to S] transition. It was calculated that L at P-5 needs the least 
energy for R to S transition among all amino acids tested [Fig. 3-14B]. This coincides 
with the result that Prk1p maximally phosphorylates its substrate with a leucine 
residue present at P-5 [Fig. 3-2C]. Furthermore, the R to S transition energy for M is 
significantly higher than that of L, I and V, albeit the lowest S to D transition energy. 
This implies that although methionine side chain can be stably docked into P-5 pocket 
at equilibrium [S to D transition energy], it requires too much energy to overcome the 
activation barrier [R to S transition energy]. Therefore it explains why M is the least 



















Structural modeling in agreement with biochemical assays. 
A. The three energy states are described here. R, relaxed. S, strained. D, docked.  
B. Various energies calculated for the five P-5 residues docked in the model.  
C. The Sybyl atom definitions for Leucine, Isoleucine, Valine and Methionine.  
D. The equilibrium docked conformations of each hydrophobic P-5 residue. A MOLC
AD surface is generated to better visualize the hydrophobic pocket created. The 
surface is colored by Lipophilic Potential: Brown representing high 
hydrophobicity, Blue representing hydrophilicity. Only the P-5 residue is shown 
in each case. The most stable docked conformation is held by Methionine, 






transition energy as M. Why then is FxxQxTG unable to be phosphorylated at a 
comparable rate as MxxQxTG by Prk1p [Fig. 3-2C]? It is because the S to D 
transition energy for FxxQxTG is prohibitively high and F residue simply can not be 
docked into the pocket. Therefore Prk1p does not recognize FxxQxTG. The docking 
of [L/I/V/M/F]xxQxTG peptides at P-5 pocket were shown in Fig. 3-14C and D.   
In conclusion, our structural modeling confirms that P-5 has to be hydrophobic, 
of the correct size [L, I and V] or be flexible enough to compact itself [M] into the 
pocket as the hydroxyl group of threonine at P0 is to lie within 2.7 Angstroms 
(Madhusudan et al., 1994) of Asp158 for phosphotransfer [Fig 3-14D]. 
 
 
3.2.G   Validation of the structural model of Prk1-KD [kinase domain] 
The homology model of Prk1-KD was created based on templates with 
approximately 30% sequence identity to the kinase. At such a low sequence identity, 
it is difficult to ascertain whether the constructed model has the correct secondary and 
tertiary folds (Marti-Renom et al., 2000), although it has provided an excellent 
structural explanation for the P-5 residue preference. To validate this model, we first 
started with the elucidation of the hydrophobic P-5 binding pocket.  
Sybyl6.8 predicted 12 plausible [P-5]-binding pockets based on lipophilic 
potential. A site made up of 3 hydrophobic residues [Ile117, Met120 and Ile238] is 
proposed as the actual pocket by its sheer proximity from the docked LxxQxTG 
motif. The distances between the H atoms from the side chain of P-5 and those from 
the 3 residues of the pocket in turn determine the strength of the interactions. As the 
Hydrogen Van Der Waals radius is 1.2 Angstrom, any distance between 2 to 3 
Angstroms will constitute a good hydrophobic interaction. Detailed analysis 





Ile117 has the most numbers of H to H interaction pairs for L [Fig. 3-15A] as well as 
I, V and M at P-5 [Data not shown]. This implies that Ile117 may be the most critical 
residue in the pocket. To verify this, Ile117 was substituted for alanine in the kinase 
domain [Prk1I117A-KD] which was then examined for any effects on the kinase 
activity towards R15 substrate. Prk1D158K-KD displayed no kinase activity as the 
negative control [Fig. 3-15B, lane 1]. This is also in accord with our structural 
modeling data pinpointing that hydrogen bonding between the carboxyl side chain of 
Asp158 and the hydroxyl group of threonine at P0 is absolutely required for phospho-
transfer. Remarkably, nor Prk1I117A-KD was able to recognize LxxQxTG motif in 
GST-R15 [Fig. 3-15B, lane 2]. I117A mutation renders Prk1-KD inactive in the 
kinase assay not due to its effect on the kinase expression level [Fig. 3-15B, α-HA 
blot], but because the mutation abrogates P-5 pocket recognition of the motif.  
We next wanted to validate whether P-2 anchor is important for the kinase 
activity. Structural modeling indicates that hydrogen bonds were formed between the 
amide group of Gln207 and the amine [Q or N] or hydroxyl [T or S] group of P-2 
residue [Fig. 3-13C]. Gln207 was substituted for alanine in the kinase domain 
[Prk1Q207A-KD] which was then examined for any effects on the kinase activity 
towards R15 substrate. Interestingly, Prk1Q207A-KD displayed an appreciable level of 
kinase activity [Fig. 3-15B, lane 4], albeit lower than wild-type kinase domain. 
Therefore Q207A does not abolish the kinase activity completely in contrast to I117A 
mutation [Fig. 3-15B, lane 2]. This suggests that although Gln207 forms hydrogen 
bonds with P-2 residue and enhances kinase recognition, it is not absolutely required. 
Quantitative densitometry indicates that Prk1Q207A-KD phosphorylates LxxQxTG in 
GST-R15-WT with a comparable intensity [20% of Prk1WT-KD, Fig. 3-15B, lane 3 

























Ile117 is the most critical residue in P-5 binding pocket. 
 
A. Hydrogen Van Der Waals interactions between leucine residue at P-5 and Ile117, 
Met120 and Ile238 respectively. The atom definition follows Fig. 3-14C. In total 
six of leucine’s Hydrogen atoms have interactions with Ile117. In contrast, only 
one interacts with Met120 or Ile238. Therefore, Ile117 plays a major role in 
recognizing the substrate peptide at P-5 position.  
B.  Specific mutations were introduced into the wild-type Prk1-KD [kinase domain] 
and assayed for kinase activities for GST-R15. D158Y was the kinase-dead, 
lacking catalytic activity completely. I117A is to mutate Ile117 at P-5 binding 
pocket to alanine. Q207A is to mutate Gln207 [involved in recognizing P-2 
residue] to alanine. The HA-tagged proteins were immunoprecipitated from equal 
amounts of cell extracts with the rabbit anti-HA antibody and analyzed on 
immunoblots [α-HA]. Phosphorylation results were shown as autoradiography and 








being mutated to A [16% of R15-WT, Fig. 3-8C]. In either case, there is no more 
Gln207 / [P-2] interaction and yet the phosphorylation still occurs with appreciable 
rates. This further confirms that the Prk1p kinase does not require P-2 recognition, 
coinciding with our previous finding that Prk1p tolerates virtually all residues at P-2 
[See Section 3.2.D]. Certainly the presence of Q/N/T/S at P-2 definitely enhances the 
phosphorylation of the substrate significantly. Comparative analysis of the in vitro 
kinase assay results [Fig. 3-8] may suggest that the contribution of P-2 residues 
towards the recognition of the whole substrate can be counterproductive as well. To 
elaborate, LxxFxTG gave rise to a phosphorylation intensity of a mere 6% of the 
LxxQxTG. In comparison, LxxAxTG in which P-2 interaction with the kinase is 
nullified still retains up to 16% of WT substrate phosphorylation. In other words, F 
having a bulky side chain is detrimental at P-2 to kinase recognition, causing a further 
reduction in phosphorylation rate.  
In summary, the structural model based on low sequence homology has 
displayed reasonable accuracy in predicting the location of P-5 pocket and P-2 
anchoring residue. These predictions have been experimentally validated accordingly. 
On the other hand, structural calculation of substrate docking energy in turn explains 
well the substrate preference of the kinase. Therefore, the model allows us to draw a 
good correlation between the structure and the enzymatic properties of the kinase.  
 
3.3 Discussion 
3.3.A   Characterization of substrate specificity for Prk1p 
Protein kinases generally fall into two major types: the serine/threonine 
[Ser/Thr] kinases and the tyrosine kinases (Krebs, 1985). The Ser/Thr kinases regulate 





phosphorylating a serine and/or threonine within it. In some cases, the serine and 
threonine residues in the recognition motifs are exchangeable. For example, both 
XS*PX and XT*PX are able to be phosphorylated by the proline-dependent protein 
kinase (Vulliet et al., 1989). Although Prk1p is a member of the Ser/Thr kinase family, 
the finding that Prk1p is unable to phosphorylate the LxxQxSG motif [see Section 
3.2.C] suggests that Prk1p could be a threonine-specific kinase. However, the 
possibility that it may phosphorylate a serine residue within a different context has not 
been ruled out. Previously, we identified the target sequence of Prk1p as LxxQxTG 
with the G at P+1 being essential and the Q at P-2 important for Prk1p recognition 
(Zeng & Cai, 1999). The requirement for L at P-5 is now investigated in this thesis 
work. This position is clearly important for Prk1p recognition, as mutation of L to A 
completely abolished the Prk1p phosphorylation [Fig. 3-2B]. Comprehensive 
mutagenesis followed by in vitro kinase assays has firmly established that Prk1p 
targets threonine phosphorylation in the context of a heptapeptide: 
[L/I/V/M]XXXXT0G [T0 denotes the target threonine]. Key features of the motif 
include a small hydrophobic residue at P-5 position and G at P+1 position. In 
addition, the presence of Q/N/T/S at P-2 cooperatively enhances the kinase 
recognition of the substrate.  
The immediate impact of this new definition of Prk1p phosphorylation motif 
is that, it uncovered more potential target sites in Pan1p and Sla1p [Fig. 3-7]. Because 
of the large numbers of potential motifs contained in Pan1p [total 19] and Sla1p [total 
21], these two proteins are the primary regulatory targets of the Prk1p kinase. The 
other significance of the elucidation of the minimal motif for Prk1p is that, we are 
able to hunt for more Prk1p-regulated target proteins in the yeast proteome. This will 





3.3.B    Similarities and differences among Prk1p family kinases 
There are 3 members in this family of kinases: Ark1p, Prk1p and Akl1p. 
Ark1p and Prk1p are more closely related based on primary sequence homology [Fig. 
3-10]. Unexpectedly, Akl1p displays a remarkably similar substrate preference as 
Prk1p [Fig. 3-12], even though Akl1p shares a lesser degree of homology than Ark1p 
with Prk1p. In agreement with our results, using synthetic peptides as substrates 
Henry and colleagues also demonstrated that Akl1p phosphorylates LxxTxTG motif 
as efficiently as Prk1p (Henry et al., 2003). In contrast, Ark1p does not recognize 
LxxTxTG, which is a canonical Prk1p target site [Fig. 3-16]. Surprisingly Ark1p was 
shown to phosphorylate LxxAxTG strongly [Fig. 3-16]. This is the first account in 
literature that Ark1p exhibits specific activity in vitro. However, when we assayed 
Ark1p activity on R15 mutated to LxxAxTG, no phosphorylation was detected. This 
discrepancy is thought to be attributed to different preparations of the Ark1p kinase in 
our studies from the published (Henry et al., 2003). For our in vitro kinase assays the 
Ark1p is tagged with HA epitope at the C-terminus. The kinase is either expressed 
under its native promoter or over-expressed under GAL1 promoter inducible by 
galactose. In vitro kinase assays on LR1 or LR2 of Pan1p both rendered negative [Fig. 
3-11B]. Henry and colleagues purified Ark1p from yeast transformed with pARK1P-
Tandem Affinity Purification [TAP]-Tag and used exactly the same in vitro kinase 
assay protocol as ours. It is not certain why Ark1p-HA is not active while TAP-
purified kinase is. One possibility is that tagging HA epitope at the C-terminus might 
hinder the kinase activity sterically; in the case of TAP purification, all the tags are 









Prk1p and Akl1p, but not Ark1p, directly phosphorylate the LxxTxTG motif in 
vitro. Immunoprecipitated GFP-tagged Prk1p or Akl1p or purified Ark1p were added 
to reactions containing 70 µg of oligopeptides [QPLKPTATGSANYL,  
PLKPTAAGSANYL, QPLKPAATGSANYL, or QPLKPAAAGSANYL]. Gels were 
silver stained to confirm equal amounts of oligopeptides in each reaction. 
Phosphorylation was detected by a Hewlett Packard Instant Imager system. [modified 
from (Henry et al., 2003) Fig 3-D] 
 
 
3.3.C   Autophosphorylation of Prk1p and Akl1p 
Most protein kinases catalyze autophosphorylation, a process which is 
generally intramolecular. Autophosphorylation affects the functional properties of 
most protein kinases. Well-characterized autophosphorylated kinases include 
mammalian signal transducer protein kinase C [PKCα]. Autophosphorylation of T638 
confers conformational stability to the kinase domain and renders it resistant to 
phosphatase attack of the critical activation loop residue T497. Hence 
autophosphorylation contributes to the activation of PKCα (Parekh et al., 2000). 
Henry and coworkers (Henry et al., 2003) have pointed out when developing 
immunoblots to quantify the amount of the GFP-tagged Prk1p and Akl1p for in vitro 
kinase assays shown in Fig. 3-16, multiple band shifts were observed. They argued 
these band shifts are indicative of autophosphorylation occurring in the kinases, which 
remains to be validated. Nevertheless, this brings our attention to the Prk1p/Akl1p 
phosphorylation motifs within the kinases themselves [Fig. 3-17A]. Two motifs are 






in Ark1p sequence]. This raises the possibility that Prk1p and Akl1p may be auto-
phosphorylating kinases. The autophosphorylation could be in cis or in trans, as these 
two kinases are probably similar in substrate specificities. Further experiments are 
required to test this hypothesis. Another interesting question is whether 
autophosphorylation of the kinases has any effect on the kinase activities as for the 
cases of PKCα. Previously when Akl1p-HA was immunoprecipitated for in vitro 
kinase assay, multiple kinase activity-dependent phospho-bands were observed [Fig. 
3-12B, lanes 1-6 vs. lane 8]. To test whether autophosphorylation bands are caused by 
phosphorylation of the C-terminus, Akl1p-KD-HA [Fig. 3-17A] encoding only the 
kinase domain was used to assay on GST-R15 substrate. Strikingly, reaction using 
kinase-domain alone did not produce the autophosphorylation bands observed in full-
length Akl1p [Akl1p-FL] [Fig. 3-17B]. Furthermore, Akl1p-KD was less active than 
Akl1p-FL towards GST-R15. These results suggest that autophosphorylated Akl1p 
has an enhanced kinase activity. Whether Akl1p indeed autophosphorylates T857 in 
vivo needs to be investigated further. 
Another interesting feature about Akl1p is that its C-terminus contains a motif 
conforming to a “pseudosubstrate” repeat [black oval in Fig. 3-17A]. These 
pseudosubstrate sequences resembling protein kinase phosphorylation site motifs are 
usually located at the regulatory domain of protein kinases. They may play an 
important role in the regulation of the kinases by maintaining them in inactive forms 
until further cellular cues (Kemp & Pearson, 1990). The pseudosubstrate sequences 
typically contain an alanine in place of the serine or threonine found in the target 
motif. For instance, PKC has a pseudosubstrate sequence between residues 22 and 27, 
RKGA25LR, which resembles the substrate motif RxxSxR with Ala25 in place of the 





the active cleft of the kinase unless diacylglycerol activates PKC, thought to induce 
conformational changes to alleviate inhibition and allow access to substrates. 
LGGTIA659G in Ak1lp is apparently a canonical pseudosubstrate sequence with the 
Ala659 in place of threonine, a good kinase phospho-acceptor otherwise. The 
presence of such site raises the possibility that the kinase activity of Akl1p may be 
















Prk1p and Akl1p may phosphorylate themselves or each other. 
A. Red ovals represent potential Prk1p/Akl1p phosphorylation sites located at the C-
terminal domains of the two kinases. Black oval represents the potential 
pseudosubstrate repeat located at the C-terminus of Akl1p. Prk1p-KD, the kinase 
domain of Prk1p. Akl1p-KD, the kinase domain of Akl1p.  
B. The HA-tagged proteins were immunoprecipitated. GST-R15 was used for in vitro 
kinase assays. K78A mutation renders the kinase inactive. Phosphorylation results 



























Prk1p Regulates Type I 
Phosphatase Targeting 





4.1    Introduction 
The substrate specificity of Prk1p has been surveyed comprehensively as 
discussed in Chapter 3. The minimal phosphorylation motif for the kinase has been 
determined as [L/I/V/M]xxxxTG. These studies were largely based on site-directed 
mutagenic GST-fusions of Pan1p fragment containing LxxQxTG sequence (Zeng & 
Cai, 1999). Results of in vitro kinase assays on these variants were then corroborated 
and extended to the other known substrate Sla1p (Zeng et al., 2001). Finally these 
results were assimilated into a pattern giving rise to the minimal [consensus] 
phosphorylation motif. Subsequently our structural model predicted several critical 
substrate-specificity determinants on the Prk1p kinase domain, which were validated 
experimentally [see section 3.2.F & G]. The next challenge is to determine whether 
the minimal phosphorylation motif can be used for predicting potential Prk1p targets 
that are previously untested.  
How to predict potential Prk1p targets? With the yeast proteome database 
available [www.yeastgenome.org], a short peptide BLAST search [PatMatch] with the 
minimal phosphorylation motif [L/I/V/M]xxxxTG generates over 1700 hits. It is 
unlikely Prk1p phosphorylates all these motif-containing proteins in vivo. Obvious 
reasons include that the localization of the kinase is restricted at the actin patches 
(Cope et al., 1999; Zeng & Cai, 1999), whereas the putative substrate proteins are not 
necessarily accessible to the kinase. For instance, the nucleus-localized proteins are 
unlikely the targets of the kinase. The fact that Prk1p regulates actin cytoskeleton and 
endocytosis has actually provided the guideline to narrow down its putative targets. 
Yeast genetics in combination with biochemical characterization have demonstrated 
more than 50 proteins are involved in the actin-coupled endocytosis (Engqvist-
Goldstein & Drubin, 2003; Smythe & Ayscough, 2006). Kaksonen and colleagues 
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employed high time-resolution imaging and provided seminal insights into the 
precisely coordinated molecular events required for actin-mediated endocytosis 
(Kaksonen et al., 2005). Based on their patch dynamics, these proteins were classified 
into four modules. [1], endocytic coat. [2], actin network growth. [3], actin dynamic 
regulation. [4], vesicle scission. To be a potential Prk1p target, a protein must satisfy 
at least 2 conditions. First, it must contain one or more recognition motifs. Second, the 
localization of the protein must allow accessibility to the kinase. In this chapter, we 
will demonstrate Prk1p phosphorylates several members from the above-mentioned 
four modules. In particular, type I phosphatase-targeting factor Scd5p will be shown 
to be phosphoregulated by Prk1p.   
 
4.2    Results  
 
4.2.A    Prk1p phosphorylates Scd5p 
One of the potential Prk1p target proteins, Scd5p contains three tandem 
LxxTxTG motifs. It was first identified from a genetic screen searching for multicopy 
suppressors of the clathrin heavy chain-deficient yeast strains (Nelson et al., 1996). 
Subsequent studies revealed that Scd5p plays an important role in cortical actin 
organization and endocytosis (Henry et al., 2002). More recently, two potential type I 
protein phosphatase [PP1] binding motifs [PBM] were identified near the N-terminus 
of Scd5p [KVDF and KKVRF, Fig. 4-1A], and the latter was sufficient to mediate 
physical interaction between Scd5p and Glc7p, the yeast PP1 known to have a 
function in actin organization and endocytosis (Chang et al., 2002). In addition to the 
PP1-binding motifs, Scd5p also contains a 20-a.a. sequence [Fig. 4-1A, solid boxes] 
repeated three times in the central region and a 12-a.a. sequence [Fig. 4-1A, hatched 
boxes] repeated nine times at the C-terminal region (Nelson et al., 1996). The newly 
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identified LxxTxTG motifs are embedded in each of the 20-aa repeats [Fig. 4-1A]. 
The resemblance between these central motifs and the previously defined Prk1p 
phosphorylation site (Zeng & Cai, 1999) has also been noted by Chang et al. (Chang 
et al., 2002). 
What are the features of Scd5p that make it stand out among various other 
putative substrates? First, Scd5p is the only protein that contains multiple identical 
motifs. The three motifs are the exact triplicate of sequence LKPTATG. Second, 
Scd5p is the only endocytic protein that has been unambiguously shown to bind to 
PP1 (Chang et al., 2002; Tu et al., 1996). Glc7p is thought to counter the histone 
protein 3 [H3] kinase Ipl1p during mitosis (Hsu et al., 2000). Likewise, Scd5 is likely 
to serve as the bridge for phosphatase activity to balance Prk1p phosphorylation. First 
we intended to validate that Scd5p may be a Prk1p substrate.  
To test whether the LxxTxTG motifs in Scd5p could be recognized by Prk1p 
in vitro, GST-fusion proteins of Scd5p containing a.a. 409 to 585 [Fig. 4-1A] were 
prepared for kinase assays. As shown in Fig. 4-1B, the motif-containing substrate 
could indeed be strongly phosphorylated by Prk1p [Fig. 4-1B, lane 1]. The 
phosphorylation was completely abolished when all three motifs were mutated [lane 
5]. Any single motif of the three was able to confer phosphorylation [lanes 2-4], 
indicating that each of them was recognized by Prk1p.  
To further confirm Scd5p as a Prk1p target, we examined whether it could be 
phosphorylated by Prk1p in vivo in cells that over-produced the kinase. Cellular 
proteins were precipitated by TCA to preserve the phospho-status of proteins, and 
dissolved in loading buffer for SDS-PAGE analysis. As shown in Fig. 4-1C, without 
PRK1 overexpression, wild-type Scd5-HA migrated as a single band on the gel [lane 






































Identification of Scd5p as a new phosphorylation target of Prk1p.  
A. Schematic diagram of Scd5p showing the locations of three LxxTxTG motifs. In 
addition to these motifs, Scd5p also contains two putative PP1-binding motifs 
[KVDF and KKVRF], three copies of a 20-aa sequence [solid boxes] and nine 
copies of a 12-aa sequence [hatched boxes]. The bar below the diagram represents 
the region used for GST-fusion protein expression.  
B. Phosphorylation of Scd5p and its mutant forms by Prk1p in vitro. The substrates 
used in each reaction are as indicated.  
C. Phosphorylation of Scd5p by Prk1p in vivo. Scd5p from YMC448 [scd5::SCD5-
HA] containing vector control pRS316 [lane 1], pGAL-PRK1D158Y [lane 2], or 
pGAL-PRK1 [lane 3], and Scd5AAAp from YMC449 [scd5::SCD5AAA-HA] 
containing either pGAL-PRK1 [lane 4] or pRS316 [lane 5] were precipitated by 





 [Fig. 4-1C, lane 5]. In contrast, in cells overexpressing PRK1 the band of Scd5p 
became smeared and retarded [Fig. 4-1C, lane 3]. This phenomenon was not observed 
for Scd5AAA-HA, which showed no changes in gel mobility upon Prk1p 
overproduction [Fig. 4-1C, lane 4]. Similarly, no mobility changes were observed for 
Scd5-HA precipitated from cells overexpressing the kinase-dead mutant of PRK1, 
PRK1D158Y [Fig. 4-1C, lane 2]. These results indicated that the gel mobility change of 
Scd5-HA extracted from Prk1p-overproducing cells was due to its phosphorylation by 
Prk1p on T416, T450, and T490 residues. We conclude therefore, that Scd5p is 
indeed phosphorylated by Prk1p in vivo.  
 
4.2.B   Suppression of the scd5-1 mutant by prk1Δ 
The above results shown in Fig. 4-1 suggested that the function of Scd5p may 
be subjected to regulation of Prk1p by phosphorylation. Furthermore, as Scd5p is also 
potentially under the regulation by the phosphatase Glc7p (Chang et al., 2002), it is 
possible that Glc7p and Prk1p could be counteracting each other on the LxxTxTG 
motifs. Scd5p interacts with Glc7p mainly through its second PP1-binding motif 
[PBM2], and disruption of this motif results in the dissociation of Glc7p from Scd5p 
accompanied by a phenotype of temperature-sensitive [TS] growth (Chang et al., 
2002). Hence, it is likely that the TS phenotype was due to overphosphorylation of 
Scd5p by Prk1p and could be expected to be suppressed by deletion of PRK1.  
To test this hypothesis, we generated an scd5 mutant [scd5-1] that carries the 
same mutations as reported by Chang et al (Chang et al., 2002) on the second PP1-
binding motif of Scd5p. Consistent with the previous report, this PBM2-disrupted 
scd5 mutant was viable at 25°C and was temperature-sensitive for growth at 37°C 
















Suppression of the scd5-1 mutation by prk1Δ. 
A. Temperature sensitivity test of the scd5-1 and prk1Δ  scd5-1 mutants. The strains 
YMC446 [scd5-1] and YMC447 [prk1Δ  scd5-1] were streaked on YEPD plates 
and incubated at respective temperatures [25°C and 37°C] for 3 days.  
B. LY uptake in wild-type [WT], scd5-1 and prk1Δ  scd5-1 cells grown at 25°C or 
incubated at 37°C for 2 h. After 2 h of incubation with LY, cells were examined 
under a microscope with FITC and Nomarski optics.  
C. Internalization of Ste3-EGFP in WT, scd5-1 and prk1Δ  scd5-1 cells grown at 
25°C. Cells containing pGAL-STE3-EGFP were induced to express Ste3-EGFP 
for 1 h and samples were taken for observation at 15-min intervals after shutdown 
of Ste3p expression.  
D. Actin staining of WT, scd5-1 and prk1Δ  scd5-1 cells grown at 25°C or incubated 
at 37°C for 4 h. Cells were fixed and incubated with rhodamine-phalloidin for 30 
min before the visualization. Bars, 5 μm. 
 
indeed be suppressed [Fig. 4-2A].  
The prk1Δ  mutation not only suppressed the TS phenotype of the scd5-1 
mutant, but also corrected the deficiencies of the mutant in endocytosis and actin 
organization characterized previously (Chang et al., 2002; Henry et al., 2002). We 
performed two types of endocytosis assays. The first one was the fluid-phase 
endocytosis using lucifer yellow [LY] as a marker. As shown in Fig. 4-2B, wild-type 
cells could efficiently internalize the dye at both 25°C and 37°C, and exhibited an 
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unambiguous vacuolar staining [Fig. 4-2B, left], whereas the scd5-1 cells failed to 
accumulate LY in vacuoles even at 25°C [Fig. 4-2B, middle]. In contrast, the prk1Δ 
scd5-1 cells showed normal LY uptake at both 25°C and 37°C [Fig. 4-2B, right]. We 
next examined the endocytosis of a plasma membrane protein Ste3p. Ste3p is the 
receptor of pheromone a-factor and is known to undergo constitutive endocytosis 
leading to degradation in the vacuole in the absence of its ligand (Davis et al., 1993). 
As shown in Fig. 4-2C, the majority of Ste3-EGFP in the wild-type cells growing at 
25°C was found to be in the vacuole 45 min after the shutdown of its expression [Fig. 
4-2C, a-e]. However, the scd5-1 mutant cells showed severe defects in this process 
[Fig. 4-2C, f-j]. Even at the last time point when no Ste3-EGFP was observed on the 
membranes of the wild-type cells [Fig. 4-2C, e], the scd5-1 cells maintained 
significant Ste3-EGFP staining on the plasma membrane [Fig. 4-2C, j]. The prk1Δ 
scd5-1 mutant cells, on the other hand, exhibited a normal pattern of internalization of 
Ste3-EGFP [Fig. 4-2C, k-o], essentially indistinguishable from that of wild-type cells. 
Similar results were also obtained with cells incubated at 37°C [our unpublished 
results]. These results indicate that the endocytosis defect of scd5-1 could also be 
suppressed by prk1Δ .  
The organization of the actin cytoskeleton was investigated by rhodamine-
phalloidin staining. Wild-type cells exhibited normal actin structures throughout the 
cell cycle at either 25°C or 37°C [Fig. 4-2D, a and d]. At 25°C, the scd5-1 mutant 
cells exhibited a nearly normal actin organization, as far as the morphology and the 
distribution pattern of the cortical actin patches were concerned [Fig. 4-2D, b]. After 
temperature shift to 37°C for 4 h, about 30-40% of the scd5-1 cells obviously showed 
aberrant actin structures [Fig. 4-2D, e]. These include depolarized cortical actin 
patches and accumulation of abnormal actin aggregates. These aberrant actin 
  
77Chapter 4 
structures, however, were no longer visible in the prk1Δ scd5-1 cells either at 25 °C or 
37°C [Fig. 4-2D, c and f]. 
In summary, our results showed that Scd5p could be recognized and 
phosphorylated by Prk1p both in vitro and in vivo in a sequence-specific manner [Fig. 
4-1B-C]. Additional evidence to support Scd5p as a regulatory target of Prk1p comes 
from the genetic interaction between scd5-1 and prk1Δ. The suppression of the 
temperature sensitivity of scd5-1 by prk1Δ  [Fig. 4-2A] suggests that the function of 
Scd5p is under a negative regulation by Prk1p, much as that of Pan1p regulated by 
Prk1p (Zeng et al., 2001). This notion is strengthened by the observation that the 
defects of the scd5-1 mutant in endocytosis and actin organization were virtually 
completely rescued by deletion of the kinase [Fig. 4-2B-D]. Together, these results 
demonstrate that Scd5p is likely another regulatory target of Prk1p. 
The nature of scd5-1 mutation [disruption of a PP1-binding motif] suggests 
that the suppression of scd5-1 by prk1Δ  is probably due to counteracting effects of 
the kinase Prk1p and the phosphatase Glc7p on the Scd5p protein. Presumably, the 
defects in the scd5-1 cells arise from a loss of access of the protein by Glc7p, as the 
region required for the interaction with the phosphatase on the mutant protein has 
been disrupted (Chang et al., 2002). As a consequence, the mutant protein may 
become persistently phosphorylated by Prk1p which evidently inhibits its activity. In 
the absence of the kinase, the mutant Scd5p protein is no longer subject to the 
phosphorylation inhibition and therefore able to function again. Alternatively, the 
suppression of scd5-1 by prk1Δ  could be mediated via other proteins that are under 
the negative regulation of Prk1p, such as Pan1p and Sla1p. This possibility, however, 
is mitigated by our observation that the temperature sensitivity of scd5-1 could not be 
suppressed by high copy PAN1 or SLA1 [data not shown]. 
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4.2.C  Constitutive dephosphorylation of Scd5p is unable to suppress scd5-1 
mutant 
 
In previous section [4.2.B], we speculate the mechanism of suppression of 
scd5-1 by prk1Δ could be that the persistently phosphorylated Scd5-1p is reduced in 
phosphorylation level as a result of PRK1 deletion. If phosphorylation on the 
threonine residues causes defects in growth and endocytosis in scd5-1, mutating the 
three threonines to alanine should mimic constitutive dephosphorylation and the 
effects of prk1Δ, therefore it should rescue scd5-1. Conversely, substitution of the 
threonines to glutamate, which mimics constitutive phosphorylation may exacerbate 
the TS phenotype of scd5-1.  Surprisingly, scd5-1+3A mutant in which P0 threonine 
was mutated to alanine for each of the three LxxTxTG motifs, showed no suppression 
of TS in comparison with scd5-1 alone [Fig. 4-3A, row c-f]. Further mutations of P-2 
threonine to alanine were introduced to scd5-1+3A similarly as published (Henry et 
al., 2003), the resultant scd5-1+6A mutant still remained TS [data not shown]. These 
data indicate that blocking phosphorylation of Scd5p alone [in the case of scd5-1+3A] 
is not sufficient to correct defects in growth and endocytosis of scd5-1. 
Furthermore, scd5-1+3E mutant in which P0 threonine was changed to glutamate for 
each of the three LxxTxTG motifs did not exhibit greater growth defect at 23oC  [Fig. 
4-3A, row g-h] or other temperatures [30oC and 34oC, data not shown] than scd5-1. 
Since deletion of PRK1 is able to suppress the TS of scd5-1, we also tested whether 
prk1Δ can suppress the TS of scd5-1+3E. Shown in Fig. 4-3B, loss of Prk1p is 
sufficient to overcome the effects of scd5-1+3E and restore its normal growth at non-
permissive temperature. These results indicate that regardless of the phosphorylation 
status, scd5-1 remains TS. Subsequently, the effects of constitutive phosphorylation 
or dephosphorylation of WT Scd5p were also examined. As shown in Fig. 4-3C, 











Constitutively unphosphorylated scd5-1 is still TS. 
A. Temperature sensitivity test of the scd5-1 and  scd5-1 in combination with its 
constitutively unphosphorylated and phosphorylated mutants. pSCD5-HA-316 is 
in scd5Δ strain to maintain viability and then various pRS315 plasmids containing 
wild type [SCD5-HA, row a and b], scd5-1 [pPBM2Δ, row c and d], scd5-1+3A 
[pPBM2Δ+3A, row e and f], scd5-1+3E [pPBM2Δ+3E, row g and h] were 
transformed. Cells were next grown on 5-FOA plate to remove pSCD5-316, 
making the pRS315 plasmids the sole sources of Scd5p. Plates were incubated at 
respective temperatures [25°C and 37°C] for 1 day. 
B. Temperature sensitivity test of the scd5-1 and  prk1Δ scd5-1 in combination with 
its constitutively phosphorylated mutants [3E]. WT, row a and b. scd5-1+3E, row 
c and d. scd5-1+3E/prk1Δ, row e and f.  
C. Temperature sensitivity test of the scd5-1 and various phospho-status mutants [3A 
and 3E]. WT, row a and b. scd5-1, row c and d. scd5-3A, row e and f. scd5-3E, 




All these data suggest that scd5-1 mutation may cause a global change in 
phosphorylation status among various other Prk1p targets, which can then be 
suppressed by the removal of the kinase. This also suggests that Scd5p could play a 
key role in mediating Glc7p-catalyzed dephosphorylation of various Prk1p substrates 
in vivo.  
 
4.3 Discussion  
4.3.A   Putative substrates of Prk1p  
Among the hits scored from the scanning of the yeast proteome with the 
minimal Prk1p phosphorylation motif, 34 proteins were singled out by virtue of their 
functions in actin cytoskeleton and/or endocytosis. 23 of them have been 
characterized as components of the four protein modules necessary for proficient 
endocytosis (Kaksonen et al., 2005).  
Among these 23 substrates, components of Module 1 are the most prominent 
group with all 10 substrates containing at least 2 motifs. In particular, Sla1p, with the 
most number of potential phosphorylation motifs, can function dually as a negative 
regulator of the actin nucleation promoting factor Las17p (Rodal et al., 2003) as well 
as a specific endocytic adaptor for cargos containing the NPFxD targeting sequences 
(Howard et al., 2002). As the core component of Module I, Pan1p is required for 
organizing endocytic coat complex. Capable of binding to F-actin, Pan1p also serves 
to couple the coated endocytic vesicle with the force-generating actin machinery. All 
four endocytic adaptors responsible for localized assembly of clathrin coats, namely 
Ent1/2p and yAP180A/B, have been verified as the true Prk1p substrates in vivo 
(Huang et al., 2003; Watson et al., 2001). Phosphorylation of these adaptors occurs in 
the vicinity of various NPF motifs which mediate their interaction with EH-domain-
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containing proteins including Pan1p and Ede1p [Fig. 3-4A; Fig. 4-4A]. Clathrin heavy 
chain [Chc1p] and Eps15 homology [EH]-and ubiquitin associated [UBA]-domain 
containing protein Ede1p are the earliest proteins known to arrive at endocytic sites 
(Newpher et al., 2005; Toshima et al., 2006). These two early coat proteins contain 
three and two motifs respectively. Interestingly, phosphorylation of Chc1p may play a 
role in the disassembly of clathrin, since Swa2p does not seem to function as a 
clathrin uncoating protein unlike its mammalian orthologue auxillin. Sla2p has an N-
terminal ANTH domain that binds PIP2, a central coiled-coil region that interacts 
with clathrin, could thus potentially link endocytic proteins to the actin cytoskeleton 
(Kaksonen et al., 2003). Its cortical localization requires functional Scd5p, which has 
already been verified as a physiological substrate under the phosphoregulation of 
Prk1p in Section 4.2. Our unpublished results have shown that Sla2p can be 
phosphorylated by Prk1p on the two motifs indicated in Fig. 4-4A.  
Eight proteins from Module 2 are also potential Prk1p substrates. These 
include yeast WASP protein Las17p and its activator Bzz1p. Another Arp2/3 complex 
activator type I myosin Myo3p and its activator Vrp1p also contain 1 motif each. 
Even three subunits of the heptameric Arp2/3 complex are candidate targets, namely, 
Arp2p, Arp3p and Arc35p. Current data are only available for verifying Las17p as a 
Prk1p substrate in vitro. The remaining ones await further examination.  
Four proteins of the Module 3 are potential Prk1p targets. Scp1p [yeast 
transgelin] and Sac6p [yeast fimbrin] cooperate to stabilize and organize the yeast 
actin cytoskeleton by cross-linking actin filaments in actin meshwork, both of which 
may be negatively regulated by Prk1p phosphorylation. Since Prk1p family kinases 
also belong to this module, interestingly, the Prk1p kinase itself and its close relative 
Akl1p may be subjected to auto-phosphoregulation. This has been expounded in 
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section 3.3.C.  
In the case of Module 4, Rvs167p [yeast amphiphysin], important for vesicle 
scission, is a candidate regulatory target of Prk1p as well. Further experiments are 
needed to explore on that.  
The remaining 11 proteins are not members of any of the core modules and 
but still grouped together for their involvement in actin cytoskeleton regulation and/or 
endocytosis [Fig. 4-4B]. For instance, Aip1p with two potential Prk1p target motifs 
promotes actin turnover by severing/depolymerizing filaments, necessary for dynamic 
remodeling of the cytoskeleton. Yeast formins [Bni1p and Bnr1p] nucleate actin 
filaments directly independent of Arp2/3 complex. Their activity is specifically for the 
assembly of actin cables but not actin patches (Evangelista et al., 2003). Furthermore 
the importance of actin cables for endocytosis is highlighted in a recent report that 
endocytic vesicles fuse with early endosomes more efficiently by their association 
with actin cables (Toshima et al., 2006). Our unpublished data have demonstrated that 
Prk1p is capable of phosphorylating Bni1p and Bnr1p in vitro. However the 
physiological significance of these phosphorylation events is yet to be determined.  
A growing body of evidence demonstrates the critical role of PtIns(4,5)P2 
[PIP2] and its phosphatases [Inp52p and Inp53p] in the control of vesicle formation 
and fission during endocytosis (Stefan et al., 2002; Stefan et al., 2005). Inp52p was 
shown to be recruited to the actin patches by Abp1p and coordinate actin 
polymerization and vesicle fission (Stefan et al., 2005). It is of enormous interest to 
examine whether phosphorylation plays a regulatory role in the activities of these 
yeast synaptojanins.  
Another potential Prk1p target Sur7p forms large immobile protein assemblies 
at the plasma membrane named eisosomes that mark endocytic sites (Walther et al., 
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2006). Akr1p is an ankryn-repeat-containing enzyme that palmitoylates Yck2p. Loss 
of Akr1p results in defective ligand-mediated endocytosis of the α-factor receptor 
Ste2p (Smotrys & Linder, 2004). Finally sphingoid bases are required for the 
internalization step of endocytosis in yeast. Ypk1/2p and its upstream kinase Pkh1p 
are important regulators of this pathway (deHart et al., 2002).  
In summary, 34 proteins have been listed in Fig. 4-4 as the putative or verified 
substrates of Prk1p. One should expect that some of those potential substrates might 













































Verified or potential substrates of Prk1p in yeast proteome. 
Proteins denoted with red colored names are either verified in vitro or in vivo or both 
as the Prk1p substrates. Proteins denoted with black names are untested putative 
substrates. Potential Prk1p phosphorylation sequences are indicated.  
A. A total of 23 putative substrates that belong to protein module 1-4 necessary for 
endocytosis. 1, endocytic coat. 2, actin network growth. 3, actin dynamic 
regulation. 4, vesicle scission.  
B. A total of 11 putative target proteins that are not classified in any of the four 
modules described and yet implicated in actin cytoskeleton organization and 




4.3.B   Scd5p is a regulatory target of Prk1p in vivo 
Scd5p can be phosphorylated by Prk1p in vitro and in vivo [Fig. 4-1B, C]. 
Ablation of the phosphatase binding site in Scd5p [scd5-1 mutant] causes TS in cell 
growth, implying that the association with Glc7p is crucial for its function. The same 
TS and defects in actin cytoskeleton and endocytosis can be rescued by deletion of 
PRK1 gene [Fig. 4-2]. These results indicate that Prk1p and Glc7p may play opposing 
roles in the regulation of Scd5p function. The scd5-1 mutation is expected to cause 
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hyperphosphorylation of the protein, as Glc7p loses its access to Scd5p. Deletion of 
the kinase Prk1p will in turn revert the phosphorylation status of Scd5-1p to a healthy 
level. However, when combining 3A mutation mimicking constitutive 
dephosphorylation with PBM2Δ, the resultant strain showed similar TS phenotype as 
PBM2Δ alone [Fig. 4-3A]. These data indicate that 3A does not encompass all the 
effects of prk1Δ, which in principle will reduce the phosphorylation levels of a far 
more comprehensive set of target proteins than Scd5p alone. Hence it is suggested 
that the inability of Scd5-1p to target phosphatase may lead to many other 
hyperphosphorylation events aside from causing itself being hyperphosphorylated. 
















































Scd5p is the  






5.1   Introduction 
It has been demonstrated that Scd5p can be phosphorylated by Prk1p in vitro 
and in vivo [Fig. 4-1B, C] in Chapter 4. Further experiments have confirmed that 
Prk1p indeed regulates the function of Scd5p by phosphorylation, as TS and defects in 
actin cytoskeleton and endocytosis associated with scd5-1 mutant can be suppressed 
by the deletion of PRK1 gene [Fig. 4-2]. It was this impairment of scd5-1 in binding 
to Glc7p and thus compromised dephosphorylation that resulted in an elevation in 
phospho-status of the protein itself. We reasoned that substitution of the 3 threonine 
residues by alanines in the phosphorylation motifs should suppress scd5-1 [in scd5-
1+3A]. Surprisingly, scd5-1+3A mutant still remained TS [Fig. 4-3A]. This implies 
that blocking phosphorylation in Scd5p alone is not sufficient to suppress scd5-1. In 
comparison, prk1Δ is sufficient to rescue the deleterious effects of scd5-1 presumably 
by blocking phosphorylation in many other substrates. These data suggest that the TS 
phenotype of scd5-1 is attributed to a global increase in phosphorylation levels of 
some other coat proteins probably including Pan1p, Sla1p, AP180s and epsins, rather 
than that of Scd5p alone. Scd5p, in turn, may function as the pivot for the phosphatase 
Glc7p to dephosphorylate these proteins.  
There are two prerequisites for Scd5p to be a Glc7p-targeting factor for 
endocytic proteins like Pan1p. 
Firstly, dephosphorylation of Prk1p substrates is a necessity for proper 
endocytosis. Phosphorylation of Pan1p, Sla1p and epsins by Prk1p has been shown to 
be a negative regulatory mechanism for the protein functions(Toshima et al., 2005; 
Watson et al., 2001; Zeng et al., 2001). Recently Toshima and colleagues have shown 
that Prk1p overexpression caused Pan1p to be mislocalized in the cytosol (Toshima et 
al., 2006), indicating that phosphorylation of Pan1p inactivates its function by 
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redistributing the protein away from the cortex. Therefore, only when Pan1p 
undergoes dephosphorylation, can the protein be recruited to endocytic sites. 
Furthermore, these endocytic proteins may experience cyclic phosphorylation and 
dephosphorylation. Real-time imaging studies have shed light on the spatio-temporal 
dynamics of endocytic factors and actin machinery (Kaksonen et al., 2003; Kaksonen 
et al., 2005). Now we understand that cytosolic Pan1p arrives at the nascent endocytic 
site early for recruiting endocytic adaptors including epsins and AP180s and 
organizing vesicle coat. Around 24 seconds after the arrival of Pan1p, the vesicle coat 
was joined by actin patch where Prk1p is found. At the end of 6 seconds of 
colocalization with the actin, the coat is disassembled upon phosphorylation by Prk1p 
and Pan1p along with other coat components is released into the cytosol. Therefore 
Pan1p totals a patch lifetime of 30 seconds. In comparison, the half-life of Pan1p 
protein is estimated to be ≈ 3 min (Belle et al., 2006). Therefore, it is highly unlikely 
that Pan1p is active at the patch for 30 seconds and afterwards remains inactive in the 
cytosol until being sent for degradation. It would be a waste of cellular resources to 
synthesize the protein and utilize it for only one endocytic internalization event before 
degradation. Hence we reason that Pan1p protein undergoes 30 seconds of patch-
phase when it is active and unphosphorylated, followed by the cytosolic phase when it 
gets phosphorylated and inactivated. Subsequent dephosphorylation is necessary to 
revitalize the protein for new rounds of endocytosis, therefore Pan1p may undergo 
multiple cycles of phosphorylation and dephosphorylation. 
Secondly, Scd5p-Glc7p complex is able to gain access to phosphorylated 
Pan1p. To suffice as a targeting factor for the phosphatase, Scd5p should be able to 
physically bind to phosphorylated Pan1p. In this chapter data supporting the notion 




5.2.A   Scd5p interacts with Pan1p genetically and physically 
A genetic interaction between Scd5p and Pan1p has been reported (Henry et 
al., 2002) that scd5-Δ388 and pan1-20 were synthetically lethal. However, the 
respective allele for scd5 was not defective in phosphatase-binding. We then tested 
whether scd5-1 [Glc7p-binding defective allele] interacts with pan1 genetically with a 
different allele pan1-4 used. The rationale was that, both scd5-1 and pan1-4 can be 
suppressed by prk1Δ, implying that both mutants may cause hyperphosphorylation of 
Pan1p (Huang et al., 2003; Zeng & Cai, 1999). Shown in Fig. 5-1A, scd5-1 mutant 
exhibited synthetic lethality with pan1-4 at room temperature, further supporting that 
these two mutants may result in synergistically deleterious effects in the same 
pathway. We next intended to test possible physical interaction between the two 
proteins by yeast two-hybrid assays. As shown in Fig. 5-1B, the N-terminal half of 
Scd5p [SCD5-N] displayed a clear interacting activity with the LR2 region of Pan1p 
[Fig. 5-1B, lower panel]. Dissection of SCD5-N into two smaller fragments yielded 
one with no binding activity [SCD5-N1] and another with an auto-activating SCD5-
N2.  To clarify this issue, we carried out in vitro binding assays using His-tagged 
Scd5p fragments and GST-LR2. The results showed that SCD5-N2, which contains 
three Prk1p phosphorylation sites [LxxTxTG] (Chang et al., 2002; Huang et al., 2003), 
could efficiently pull down GST-LR2 [Fig. 5-1C, lane 6]. The interaction between 
Scd5p and Pan1p was further confirmed by co-immunoprecipitation. Endogenously 
expressed Scd5-HA could be pulled down by the anti-Myc antibody when Pan1-Myc 
was co-expressed [Fig. 5-1D, lane 4], indicating that Scd5p is in a complex with 




Interactions of Scd5p with Pan1p.  
A. YMC472 transformed with pRS314 or pPAN1-314 were tested for growth on 
synthetic complete medium containing 1 mg/ml of 5-FOA at 25°C for 5 days.  
B. Two-hybrid interactions of Scd5p with Pan1p. The regions of Scd5p and Pan1p 
used for two-hybrid assays were schematically shown in the upper panel. Domains 
and motifs important for each protein are also indicated.  PBM, phosphatase 
binding motif; LR, long repeat; EH, Eps15 homology; C.C., coiled-coil; A, acidic 
motif; P.P., poly-proline. Two-hybrid interactions were quantified by measuring 
β-galactosidase activity and expressed in Miller units with S.D. Results are the 
average of three independent transformants and presented as bar graphs. auto, 
auto-activity; n.d., not determined. 
C. In vitro binding assays between Scd5p and Pan1p.  Different fragments of His-
tagged Scd5p [arrows] were bead-immobilized and incubated with GST-LR2 
[arrow head] or GST, respectively. The precipitates, as well as portions of GST 
and GST-LR2 [loaded on lanes 1-2 as positive controls], were separated by gel 
electrophoresis and sequentially immunoblotted with anti-GST and anti-His 
antibodies. A cross-reaction between anti-GST antibody and His-SCD5-C was 
observed [lanes 7-8].  
D. Coimmunoprecipitation of Scd5p with Pan1p. Yeast extracts prepared from 
YMC448 [lanes 1, 5, and 7], YMC441 [lanes 2, 6, and 8], or YMC471 [lanes 3-4, 
and 9], were subjected to anti-Myc or anti-HA immunoprecipitation followed by 
gel electrophoresis, and then immunoblotted with anti-Myc and anti-HA 





5.2.B   Scd5p patch coincides with Pan1p patch spatio-temporally 
The results showing that Scd5p and Pan1p are in the same complex [Fig. 5-1] 
prompted us to study the dynamic localization of these two proteins using live cell 
imaging. Based on the physical interactions between them, we could speculate that 
these two should have similar dynamics. In agreement with previous studies 
(Kaksonen et al., 2003; Kaksonen et al., 2005; Sun et al., 2006), the Pan1-GFP 
labeled cortical patches showed restricted movement and exhibited a patch lifetime of 
about 28 s [Fig. 5-2A-B]. The Scd5-GFP patches were virtually of the same pattern of 
dynamics with a life span of about 27 s [Fig. 5-2A-B]. Two-color imaging revealed 
that Scd5-GFP was recruited to cortical patches at the same point as Pan1-CFP, and 
the two proteins colocalized with each other on most of the patches, and disappeared 
together in the end [Fig. 5-2C-D]. Fluorescent intensities of the patches over frames 
were quantified for both proteins. Remarkably, Scd5p and Pan1p display identical 
pattern of increasing first and then decreasing. Furthermore, they both peak at the 
same time [Fig. 5-2E], suggesting that Pan1p and Scd5p are tightly associated within 
the coat complex. Therefore Scd5p belongs to the coat module described in Section 
1.3.A, behaving similarly with other endocytic coat proteins like Sla1p, End3p and 
Sla2p (Kaksonen et al., 2005). 
 
5.2.C   Scd5p was unable to bind to phosphorylated Pan1p 
Toshima and colleagues demonstrated overexpressing Prk1p renders almost 
complete loss of Pan1p patches in the cortex (Toshima et al., 2006), suggesting that 
Pan1p in the cytosolic pool is phosphorylated. In wild type cells, following the patch-
phase, Pan1p gets phosphorylated and redistributed into the cytosol. If Scd5p-Glc7p is 






Live cell imaging of Pan1p, Scd5p and Prk1p patches.   
A. Single frames from movies of live cells expressing Pan1-GFP [YMC494] and 
Scd5-GFP [YMC496]. Movies were taken with the frame intervals of 2 s for 
Pan1-GFP and 4 s for Scd5-GFP.  
B. Lifetimes of Pan1-GFP and Scd5-GFP patches in wild-type cells. n ≥ 30 for each 
protein.   
C. Single frames from two-color movies of live cells expressing Pan1-CFP and Scd5-
GFP [YMC498]. Movies were taken with frame intervals of 5 s.  
D. Time series from two-color movies showing the dynamic localization of Scd5-GFP 
with reference to Pan1-CFP.  




Pan1p in the same way as during the patch-phase. Therefore we next examined 
whether Scd5p could still bind to Pan1p upon phosphorylation.  
Shown in Fig. 5-1, the association between Scd5p and Pan1p is essentially 
mediated by the N2 region of Scd5p and LR2 of Pan1p. Interestingly, LR2 region 
alone harbors 13 of the 19 phosphorylation motifs present in the entirely Pan1p 
sequence [Fig. 3-7], suggesting that effects on LR2 region may represent much of 
phosphoregulation of the whole Pan1p protein by Prk1p. Firstly GST-LR2 was 
phosphorylated in vitro. To phosphorylate LR2 fully, ATP input is given a 100-fold 
increase and reaction time is 4-fold longer than our previous kinase assays with Prk1p 
and Ark1p using the same GST fusions [Fig. 3-11C]. A clean band-shift was observed 
for fully-phosphorylated GST-LR2 [Fig. 5-3A]. In contrast, in the previous assays no 




Scd5p cannot bind to phosphorylated Pan1p. 
A. In vitro phosphorylation of Pan1p by Prk1p. Purified GST-LR2 was incubated with 
immunoprecipitated HA-Prk1p [lanes 3-4] or HA-Prk1D158Yp [lane 2] in the 
presence [lanes 2 and 4] or absence [lane 3] of non-radioactive ATP at 25°C for 3 
h.  The mixture was separated by gel electrophoresis and immunoblotted with 
anti-PThr and then anti-GST antibodies. 
B. In vitro binding assays between Scd5p and phosphorylated Pan1p. His-tagged 
SCD5-N2 was immobilized and incubated with unphosphorylated GST-LR2 [lane 
3] and phosphorylated GST-LR2P [lane 4], respectively. The precipitates, together 
with portions of GST-LR2 and GST-LR2P [lanes 1-2], were separated by gel 






phosphorylated given the limiting reaction conditions. Unphosphorylated and fully 
phosphorylated GST-LR2 were then tested for their affinities for His-SCD5-N2. It is 
important to fully phosphorylate GST-LR2 for the in vitro binding assay because 
unphosphorylated or partially phosphorylated GST-LR2 from incomplete kinase 
reactions will become contaminants and might give rise to wrong interpretation of the 
binding assay results. Shown in Fig. 5-3B, beads-bound His-SCD5-N2 readily pulled 
down unphosphorylated LR2 [lane 3] but not phosphorylated LR2 [lane 4]. These 
results indicate that Scd5p is unable to target Glc7p to hyperphosphorylated Pan1p in 
the cytosol unless addition targeting factor (s) exists.  
 
5.2.D   Scd5p binds to End3p-Pan1p complex 
Earlier on it was shown that Scd5p cannot bind to phosphorylated Pan1p, 
mitigating the possibility that Scd5p directly target Glc7p to Pan1p. Then it was 
proposed that Scd5p-Glc7p may require an additional targeting factor (s) in order to 
dephosphorylate Pan1p efficiently. Since Pan1p forms a trimeric complex with Sla1p 
and End3p (Tang et al., 2000), it is likely that Scd5p may bind either or both of these 
two Pan1p-binding partners so as to indirectly access Pan1p. Possible interactions 
between Scd5p and Sla1p or End3p were then tested. We could not, however, detect 
an interaction between Scd5p and Sla1p, by the two-hybrid assay [data not shown]. 
Concurrently possible physical interaction between Scd5 and End3p was also 
examined in yeast two-hybrid assays. It was revealed that SCD5-N could bind to the 
N-terminus but not the C-terminus of End3p [Fig. 5-4B]. This result was again 
supported by co-immunoprecipitation experiments [Fig. 5-4C]. Lane 9-11 are Co-IP 
lanes, indicating that End3ΔC [lane 11] could bind to Scd5p as strongly as End3-FL 
[lane 9], while End3ΔΝ had no affinity for Scd5p [lane 10]. Taken together, N-
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terminus of End3p mediates its interaction with Scd5p. In contrast, it is the C-
terminus of End3p that is responsible for binding to Pan1p (Tang et al., 1997). 
Therefore, End3p can potentially bind to Scd5p and Pan1p simultaneously. 
Genetic evidence was also available to support the notion that End3p may 
facilitate Scd5p-Glc7p targeting to cytosolic Pan1p. scd5 was shown to interact with 
end3 genetically as scd5-Δ338 was synthetically lethal with end3Δ (Henry et al., 
2002). As a further proof, we verified the genetic interaction between scd5 and end3 
using scd5-1 which harbors the precise mutation to abolish its Glc7p-binding activity 
(Chang et al., 2002). As shown in Fig. 5-4A, scd5-1 also exhibited synthetic lethality 
with end3Δ, suggesting that these two proteins are functionally related. 
 If End3p facilitates Scd5p to attack phosphorylated Pan1p, a critical question 
should be addressed next: does Scd5p-End3p bind to phosphorylated Pan1p since 
Scd5p alone is unable to do so? Three lines of evidence have converged to support 
this possibility. Firstly, End3p retains a detectable albeit significantly reduced binding 
to overly phosphorylated versus unphosphorylated LR2 region of Pan1p (Zeng et al., 
2001). Secondly, preincubaion of excessive End3p with LR2 greatly diminished its 
phosphorylation by Prk1p, indicating End3p was able to hinder Prk1p access to Pan1p 
in vitro (Zeng & Cai, 1999). Thirdly, Toshima and colleagues used TAP [Tandem 
Affinity Purification]-tagged Pan1p under endogenous promoter to identify associated 
proteins. End3p and Pan1p were recovered in a stable complex with a 1:1 binding 
stoichiometry (Toshima et al., 2006). Remarkably, this native complex of Pan1p-
End3p was highly resistant to exaggerated phosphorylation by Prk1p (Toshima et al., 
2006) unlike assays with Pan1p in the absence of End3p (Toshima et al., 2005). 
Unprotected Pan1p has received maximal phosphorylation when incubating with the 




Scd5p interacts with End3p genetically and physically.  
A. Genetic interactions of Scd5p with End3p. YMC475 transformed with pRS314 or 
pEND3-314 were tested for growth on synthetic complete medium containing 1 
mg/ml of 5-FOA at 25°C for 5 days for counter-selecting the loss of pEND3-316. 
B. Two-hybrid interactions of Scd5p with End3p. The regions of End3p used for two-
hybrid assays were schematically shown on upper panel. Domains and motifs are 
also indicated. EH, Eps15 homology; PIP2, phosphatidylinositol 4,5-bisphosphate 
binding motif; ER, End3p repeat. Two-hybrid interactions were quantified by 
measuring galactosidase activity and expressed in Miller units with S.D. Results 
are the average of three independent transformants and presented as bar graphs. 
C. Coimmunoprecipitation of Scd5p with End3p. Yeast extracts prepared from 
YMC448 [lanes 8 and 13], YMC474 containing pMyc-End3-314 [lane 2], 
YMC474 containing pMyc-End3ΔN-314 [lane 3], YMC474 containing pMyc-
End3ΔC-314 [lane 4], YMC476 containing pMyc-End3-314 [lanes 5, 9, and 14], 
YMC476 containing pMyc-End3ΔN-314 [lanes 6, 10, and 15], and YMC476 
containing pMyc-End3ΔC-314 [lanes 7, 11, and 16], were subjected to anti-Myc 
or anti-HA immunoprecipitation followed by gel electrophoresis, and then 





phosphorylation also resulted in the single band retarded in motility. In stark contrast, 
when incubating End3p-complexed Pan1p with equal amount of Prk1p only mild 
phosphorylation occurred indicated by a slight trailing of the band with the majority 
remaining in the lower [thus unphosphorylated] motility position. Therefore, bound 
End3p in the native complex indeed protects Pan1p from excessive phosphorylation 
by Prk1p in vitro. More importantly, the amount of End3p associated with Pan1p 
upon phosphorylation was largely unchanged, suggesting that End3p-Pan1p complex 
is extremely stable. These data also led us to speculate that under in vivo conditions, 
probably moderate extent of phosphorylation of Pan1p is sufficient to disrupt the 
integrity of the coat module and trigger coat disassembly. More importantly, 
phosphorylation on Pan1p protected by End3p might be still reversible by available 
dephosphorylation machinery. One extreme scenario is that in cells over-expressing 
Prk1p, Pan1p completely loses its cortical patch localization (Toshima et al., 2006) as 
a result of excessive phosphorylation by the kinase beyond the capacity of the 
dephosphorylation machinery. Taken together, stable complex formation between 
End3p and Pan1p is critical for Scd5p-Glc7p to dephosphorylate and reactivate 
cytosolic Pan1p.  
 
5.2.E    Glc7p-Scd5p-End3p mediates dephosphorylation of Pan1p in vivo 
Thus far, we have established the interaction network between the phosphatase 
[Glc7p]/potential targeting subunits [Scd5p and End3p] and the substrate 
[phosphorylated Pan1p] biochemically and genetically. Whether Glc7p-Scd5p-End3p 
mediates dephosphorylation of Pan1p in vivo is yet to be determined. Monitoring the 
steady-state phosphorylation level of endogenously expressed Pan1p at various 
genetic backgrounds where precise mutations were introduced to perturb specific 
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component of the putative dephosphorylation machinery, will provide valuable insight 
into how Pan1p is dephosphorylated. Myc epitope was fused to the C-terminus of 
Pan1p at its chromosomal locus to maintain its endogenous expression. The protein 
was immunoprecipitated and probed with a phosphothreonine-specific antibody [anti-
PThr], as shown in Fig. 5-5A [left, lane 2]. The antibody is specific for 
phosphorylated as opposed to unphosphorylated threonines, generating no signal in 
lane 1 of calf intestinal phosphatase [CIP] treated wild-type sample [left, lane 1]. As 
expected, the phosphorylation level was drastically reduced in the prk1Δ mutant to 
about 15% of that of WT [left, lane 3 and right]. This result indicates that Prk1p is the 
primary one responsible for the phosphorylation of Pan1p among the three Prk1 
family kinases in vivo.  
To verify whether Scd5p-Glc7p is involved in the dephosphorylation of Pan1p, 
the phosphorylation level of Pan1p was likewise examined in scd5-1 mutant. As 
demonstrated in Fig. 5-5B, phosphorylation level of Pan1p is significantly higher in 
scd5-1 than in WT cells at both permissive [over 3-fold] and non-permissive 
temperatures [over 5-fold]. Interestingly, temperature shift from 25oC to 37oC also 
resulted in a 1.9-fold increase of phosphorylation level in WT cells [lane 1 and 3], 
suggesting that the kinase activity may be enhanced at higher temperatures. Therefore 
the 3.4-fold increase of Pan1p phosphorylation level in scd5-1 upon temperature shift 
should be a combinatorial contribution of increased kinase activity and impairment of 
Glc7p recruitment. These results show that the phosphorylation status of Pan1p in 
vivo is dependent on the activity of Scd5p.  
Previously, we have shown that Scd5p binds to unphosphorylated Pan1p but 
not phosphorylated Pan1p [Fig. 5-3]. However, End3p may bridge Scd5p and 

























In vivo phosphorylation level of Pan1p is regulated by Prk1p, Scd5p and End3p.  
Endogenously expressed Pan1-Myc was immunoprecipitated from cells and 
sequentially immunoblotted with anti-PThr and anti-Myc antibodies. The 
phosphorylation level of each protein was measured by densitometer and normalized 
against its amount. The relative phosphorylation intensities were then calculated and 
presented as bar graphs [right panels]. 
A. Pan1-Myc from YMC441 [lanes 1 and 2] and YMC478 [lane 3] cells at 30°C. The 
immunoprecipitates in lane 1 were incubated with 1 μl of CIP for 30 min at 37°C 
prior to loading.   
B. Pan1-Myc from YMC441 [lanes 1 and 3], and YMC479 [lanes 2 and 4] cells at 
either 25°C [lanes 1-2] or 37°C for 2 h [lanes 3-4].   
C. Pan1-Myc from YMC441 [lanes 1 and 3] and YMC480 [lanes 2 and 4] cells at 






analysis indicates that the affinity of Scd5p for End3p is close to 10 times greater than 
that for Pan1p [Fig. 5-1B and 5-4B]. Therefore, we speculate that End3p could be the 
preferred entry point for Scd5p-Glc7p to gain access to phosphorylated Pan1p. To test 
this possibility, the phosphorylation status of Pan1p is monitored in end3Δ cells. 
Conspicuously, deletion of END3 gene causes more than 20-fold increase in 
phosphorylation level of Pan1p at 25oC over WT cells [Fig. 5-5C]. Temperature shift 
to 37oC resulted in a further 60 % increase in Pan1p phosphorylation level, which 
could be solely attributed to the increase in kinase activity as we also observed in WT 
cells. Hence these data suggest that deletion of END3 gene would have already led to 
a complete failure in the dephosphorylation of Pan1p at permissive temperature as the 
bridge between phosphorylated Pan1p and Scd5p-Glc7p no longer exists. 
To further dissect out the crucial domains of End3p capable of bridging 
Scd5p-Glc7p and Pan1p, 2 truncation mutants were created in which either its N- and 
C- terminus was removed [Fig. 5-6A]. The rationale is that End3p interacts with 
Scd5p and Pan1p through its N- and C- terminal regions respectively, hence either of 
the two truncations should disable its function as a bridging agent between Scd5p and 
Pan1p, resulting in an increase in the level of Pan1p phosphorylation. This was indeed 
the case [Fig. 5-6B, right panel], as end3-ΔN and end3-ΔC led to 3.4- and 1.6-fold 
increase in phosphorylation level over end3-FL cells respectively. Comparing with 
the complete deletion of END3 gene [Fig. 5-5C], these two truncations had 
significantly less acute effects in elevating Pan1p phosphorylation state, suggesting 
that removal of either N- or C-terminus alone does not halt the dephosphorylation 
process completely. This is also consistent with the observation that neither truncation 
causes TS at 37oC [Fig. 5-6C, row 3-4]. The effects of the truncations on full-length 






Phosphorylation level of Pan1p in end3 truncation mutants.   
A. Endogenously expressed Pan1-Myc was immunoprecipitated from cells and 
sequentially immunoblotted with anti-PThr and anti-Myc antibodies. Pan1-Myc 
from YMC480 cells containing pEND3-314 [lane 1], pEND3ΔN-314 [lane 2], or 
pEND3ΔC-314 [lane 3] at 30°C.   
B. The full-length Pan1p protein amount in each sample was measured by 
densitometer and normalized against G6PDH control. The phosphorylation level 
of Pan1-Myc in each sample was measured by densitometer and normalized 
against its protein amount. The relative protein expression amount and 
phosphorylation intensities were calculated and presented as bar graphs. 
C. Temperature sensitivity test of truncation mutants end3ΔN [row 3] and end3ΔC 
[row 4]. pEND3- 314 [row 1] or pRS314 vector [row 2] was transformed in end3Δ 
strain to serve as positive and negative controls respectively. Two dilutions of the 
cultures [1:10, initial OD=0.5] were spotted on YEPD plates, which were then 
incubated at the indicated temperatures for 2 days.  
 
 
5.2.F   Glc7p is the upstream phosphatase for Pan1p and Scd5p 
In previous sections, we have confirmed that Scd5p-End3p functions to target 
phosphatase to Pan1p. However, whether Glc7p is the true upstream phosphatase 
remains untested. If Glc7p is indeed the phosphatase responsible for the 
dephosphorylation of cytosolic Pan1p, disruption of Glc7p activity should elevate the 
phosphorylation level of Pan1p in vivo. Applying phosphatase inhibitors will produce 




[Ppz1, Ppz2 and Sal6] found in yeast share some functions and targeting subunits with 
Glc7p (Venturi et al., 2000) and are inhibited to some extent by PP1-specific 
inhibitors (Garcia-Gimeno et al., 2003). Hence we attempted a different approach to 
deplete Glc7p in vivo using the degron strategy (Dohmen et al., 1994). By integrating 
at the glc7 chromosomal locus a heat-inducible degradation signal [ubiquitin-Arg-
DHFRTS] and an HA epitope in frame with the Glc7p N terminus, the glc7-td strain 
thus was created. Glc7p undergoes rapid degradation after shifting glc7-td cells to 
37°C for 30 min and becomes almost undetectable after 60 min [Fig. 5-7A, lane 4-6]. 
The control strain glc7-ntd [non-TD] was created similarly except with Leu66 
substituted by Pro in the DHFR [dihydrofolate reducase] moiety of Ub-Arg-DHFRTS-
HA-Glc7p. This substitution stabilizes the fusion protein structurally at 37oC 
(Dohmen et al., 1994) and protects it from heat-induced degradation [Fig. 5-7A, lane 
1-3]. It is evident that the phosphorylation level of Pan1p in glc7-td cells increased in 
accordance with the depletion of Glc7p, while remained unchanged if Glc7p was not 
degraded in glc7-ntd strain [Fig. 5-7A]. Quantitative densitometry revealed that 
depletion of Glc7p gave rise to a 5.3-fold increase in Pan1p phosphorylation level 
[Fig. 5-7A, right panel], implying that Glc7p is indeed the upstream phosphatase for 




















Glc7p is the upstream phosphatase for Pan1p in vivo. 
A. Pan1p phosphorylation level in glc7-td mutant.  YMC484 and YMC485 cells were 
allowed to grow to the log phase at 25°C and then shifted to 37°C. Samples were 
taken at 0, 30, and 60 min, and Pan1p-Myc was immunoprecipitated, 
electrophoresed, and immunoblotted with anti-PThr and then anti-Myc antibodies. 
Total proteins of each sample were also extracted by TCA method and subjected 
to western analysis with G6PDH as the loading control for the examination of the 
expression level of Glc7p. 
B. Pan1p phosphorylation level in glc7-T152K mutant. Pan1-Myc wasimmunoprecipi
tated from YMC441 [lane 1] and YMC482 [lanes 2-3] cells grown at 30°C, 
electrophoresed, and immunoblotted with anti-PThr and then anti-Myc antibodies. 
The immunoprecipitates in lane 3 were preincubated with CIP for 30 min prior to 
loading. The phosphorylation levels of Lane 1 and 2 were measured by 
densitometer and normalized against its protein amount, and presented as bar 
graphs [right panel]. 
 
As a further proof of Glc7p’s involvement in the dephosphorylation process, 
another mutant, glc7-T152K, previously characterized to be defective in association 
with Scd5p (Tu et al., 1996), also exhibited an elevated level of Pan1p 
phosphorylation [Fig. 5-7B]. These results allowed us to conclude that Glc7p, through 
its binding to Scd5p, is required for dephosphorylation of Pan1p in vivo.  
In comparison with Pan1p which requires additional targeting factor End3p-




directly bind to the phosphatase via its PBM sequence for possible dephosphorylation. 
Previously, we have demonstrated Prk1p phosphorylates and antagonizes the 
functions of Scd5p [Chapter 4]. Whether Glc7p directly dephosphorylates Scd5p in 
vivo in opposition to Prk1p has not been investigated. To answer this question, steady 
state phosphorylation level of Scd5p was examined in prk1Δ cells and various glc7 
mutants versus WT cells [Fig. 5-8]. Unexpectedly, endogenous Scd5p tagged with 
HA at the C-terminus is apparently highly dephosphorylated as it was undetectable by 
anti-PThr probing [data not shown]. This result suggests that tightly associated Glc7p 
would immediately erase any phosphorylation on Scd5p by Prk1p and thus maintain 
its dephosphorylated status. Therefore, this close-to-none level of phosphorylation in 
vivo poses a great problem to assess the possible regulatory roles of Prk1p and Glc7p. 
One way to overcome this challenge involves treating the cell culture with a cocktail 
of phosphatase inhibitors [which later are also added into the lysis buffer, described in 
Chapter 2] for 2 hours before harvesting so as to raise the basal level of 
phosphorylation in Scd5p. Indeed, the phosphorylation level of WT Scd5p then 
became detectable [Fig. 5-8A, lane 1]. More importantly it significantly dropped by 
two-thirds when deleting the PRK1 gene [lane 4 and right panel], indicating that 
Prk1p is again the major kinase responsible for phosphorylating Scd5p in vivo. 
Furthermore, Scd5AAA mutant in which the 3 phosphorylation sites have been mutated 
to alanines completely abolished phosphorylation [lane 3]. 
To test whether Glc7p is the upstream phosphatase for Scd5p, a similar 
strategy shown in Fig. 5-7A was employed here. When depleting Glc7p in vivo after 
shifting glc7-td cells for 60 min, a 5.6-fold leap in Scd5p phosphorylation was 
observed [Fig. 5-8B]. To further explore the importance of the interaction between 
Scd5p and Glc7p for the efficient dephosphorylation process of Scd5p, specific alleles 
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Glc7p is the upstream phosphatase for Scd5p in vivo. The phosphorylation level of 
each protein was measured by densitometer and normalized against its amount.  The 
relative phosphorylation intensities were then calculated and presented as bar graphs 
[right panels]. 
A. Phosphorylation of Scd5p in vivo. YMC448 [lanes 1-2], YMC449 [lane 3] and 
YMC488 [lane 4] cells expressing either Scd5-HA [lanes 1-2 and 4] or Scd5AAA-
HA [lane 3] were grown at 30°C and incubated with phosphatase inhibitor 
cocktail for 2 h. The HA-tagged proteins were immunoprecipitated, 
electrophoresed and immunoblotted with anti-PThr and then anti-HA antibodies.  
The immunoprecipitates in lane 2 were treated with CIP for 30 min prior to 
loading.  
B. Scd5p phosphorylation level in glc7-td mutant. Log phase YMC492 and YMC493 
cells at 25°C were incubated with phosphatase inhibitor cocktail for 2 h, and 
shifted to 37°C. Samples were taken at 0 and 60 min, and Scd5-Myc was 
immunoprecipitated, electrophoresed and immunoblotted with anti-PThr and then 
anti-Myc antibodies. The expression level of Glc7p in each time point was also 
assayed by western analysis.   
C. Scd5p phosphorylation level in cells containing either T152K mutation on Glc7p 
or PBM2Δ mutation on Scd5p. Log phase YMC487 [lanes 1 and 3], YMC490 
[lane 4], and YMC489 [lane 2] cells at 25°C were shifted to 37°C for 4 h with 
phosphatase inhibitor cocktail present during the last 2 h. The HA-tagged proteins 
were immunoprecipitated, electrophoresed and immunoblotted with anti-PThr and 




causing perturbations in the binding of the two were examined for any effects. 
Deletion of the PBM in Scd5p [scd5-1] evidently led to 3.7 times more 
phosphorylated Scd5p as a result of disruption in Scd5p-Glc7p interaction [Fig. 5-8C, 
lane 1 and 2, right panel]. Consistently, a 5.9-fold elevation in the phosphorylation 
state of Scd5p was observed in glc7-T152K mutant, which was deficient in Scd5p 
binding. Therefore, still being able to observe these hyperphosphorylation events 
suggests that pretreatment with the inhibitor cocktail only partially inhibited Glc7p, 
which in turn validates this approach for not causing maximal phosphorylation of 
Scd5p.    
In conclusion, Glc7p acts in opposition to Prk1p to regulate the 
phosphorylation status of Pan1p as well as Scd5p in vivo.  
 
5.2.G   Glc7p dephosphorylates Pan1p and Scd5p in vitro.  
If Glc7p is to antagonize Prk1p phosphorylation of Pan1p and Scd5p, then 
purified Glc7p should be able to dephosphorylate them in vitro. To test this prediction, 
HA-tagged Glc7p was purified by immunoprecipitation from yeast cell extracts. The 
immunoprecipitants were then assayed for their ability to dephosphorylate Pan1p or 
Scd5p. To obtain the phosphorylated form of Pan1p, GST-LR1, which contains 6 
Prk1p phosphorylation sites [Fig. 3-7A], was subjected to phosphorylation by Prk1p  
in the presence of non-radioactive ATP.  As shown in Fig. 5-9A, GST-LR1 could be 
detected by the anti-PThr antibody after an incubation with immunoprecipitated HA-
Prk1p, and no signal was detected if a kinase-dead mutant, Prk1D158Yp (Zeng & Cai, 
1999), was used. The phosphorylated GST-LR1 thus obtained gradually reduced its 
phosphorylation level during incubation with immunoprecipitated Glc7-HA to, for 
example, about 30% after 80 min [Fig. 5-9B-C]. This reduction in GST-LR1 
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phosphorylation was effectively blocked by I-2, a phosphatase inhibitor formerly 
demonstrated to be specific for type 1 protein phosphatases (Cohen et al., 1989). 
Similar results were also obtained using GST-LR2 as the substrate in the assay [Fig. 
5-10]. These experiments confirmed that Glc7p could execute dephosphorylation of 
Pan1p in vitro.  
Next we performed a similar dephosphorylation assay as described above to 
Scd5p. Purified GST-SCD5 [Fig. 4-1] was first made suitable for in vitro phosphatase 
assay by incubating with non-radioactive ATP and Prk1p, and the resulted 
phosphorylated GST-SCD5 was assayed with immunoprecipitated Glc7-HA.  As 
shown in Fig. 5-11, Glc7p could efficiently dephosphorylate GST-SCD5 in vitro.  
Again, a pre-incubation with I-2 completely inhibited the Glc7p activity. 
In summary, Glc7p is capable of dephosphorylating Pan1p and Scd5p in vitro.   
 
 
Glc7p dephosphorylates phospho-LR1-Pan1p in vitro. 
A. In vitro phosphorylation of Pan1p by Prk1p. Purified GST-LR1 was incubated with 
immunoprecipitated HA-Prk1p [lanes 3-4] or HA-Prk1D158Yp [lane 2] in the 
presence [lanes 2 and 4] or absence [lane 3] of non-radioactive ATP at 25°C for 3 
h. The mixture was separated by gel electrophoresis and immunoblotted with anti-
PThr and then anti-GST antibodies.   




with or without the I-2 treatment was incubated with in vitro phosphorylated GST-
LR1 at 37°C. Samples were taken at 20 min intervals, electrophoresed and 
immunoblotted with anti-PThr and anti-GST antibodies.   
C. Measurement of Glc7p phosphatase activity on LR1. The phosphorylation level of 
GST-LR1 at each time point was measured by densitometer and normalized 
against its protein amount. The relative phosphorylation intensities of later time 






Glc7p dephosphorylates phospho-LR2-Pan1p in vitro. 
A. In vitro dephosphorylation of LR2-Pan1p by Glc7p. Immunoprecipitated Glc7-HA 
with or without the I-2 treatment was incubated with in vitro phosphorylated GST-
LR1 at 37°C. Samples were taken at 20 min intervals, electrophoresed and 
immunoblotted with anti-PThr and anti-GST antibodies.   
B. Measurement of Glc7p phosphatase activity on LR2. The phosphorylation level of 
GST-LR2 at each time point was measured by densitometer and normalized 
against its protein amount. The relative phosphorylation intensities of later time 
points were calculated against the time point of 0 min. 
 
 
Glc7p dephosphorylates phospho-Scd5p in vitro. 
A. In vitro dephosphorylation of Scd5p by Glc7p. Immunoprecipitated Glc7-HA with 
or without the I-2 treatment was incubated with in vitro phosphorylated GST-LR1 
at 37°C. Samples were taken at 20 min intervals, electrophoresed and 
immunoblotted with anti-PThr and anti-GST antibodies.   
B. Measurement of Glc7p phosphatase activity on Scd5p. The phosphorylation level 
of GST-Scd5p at each time point was measured by densitometer and normalized 
against its protein amount. The relative phosphorylation intensities of later time 





5.2.H   Phosphoregulation of Scd5p by Prk1p and Glc7p 
We have established that Glc7p requires Scd5p-End3p to dephosphorylate 
cytosolic Pan1p in vivo. In addition, Scd5p targets Glc7p to itself once it gets 
phosphorylated by Prk1p. The dilemma for Scd5p regulation is that since it is largely 
unphosphorylated owing to the bound Glc7p, does it imply that phosphorylation of 
Scd5p by Prk1p is of little biological significance?   
Next the effects of Scd5p phosphorylation were investigated. Prk1p 
phosphorylation has been shown to suppress the multivalent interaction between 
Pan1p and other proteins (Toshima et al., 2005; Zeng et al., 2001). The recurring 
scheme for phosphoregulation is that phosphorylation modulates protein-protein 
interaction. Both Pan1p and End3p bind to the region of Scd5p where the three Prk1p 
phosphorylation sites are located. Mutations were made to convert the three T 
residues into either A or E, mimicking unphosphorylated and phosphorylated states of 
Scd5p respectively. Two-hybrid assays revealed that these mutations affected the 
interactions of Scd5p with both Pan1p and End3p, but not with Glc7p [Fig. 5-12A-C]. 
Compared with the wild-type, Scd5AAAp exhibited a stronger binding activity with 
both Pan1p and End3p [increased to 196% for Pan1p and 125% for End3p], whereas 
Scd5EEEp showed a considerably reduced binding, to about 60%, with the two proteins 
[Fig. 5-12A and B]. These results are of a good indication that the interactions of 
Scd5p with Pan1p and End3p are both negatively regulated by phosphorylation on 
Scd5p. The binding with phosphatase Glc7p, on the other hand, remained at a similar 
level irrespective of mutations [Fig. 5-12C], suggesting that the Scd5p-Glc7p 
interaction was not affected by Scd5p phosphorylation. This constant interaction 
between the two provides the underlying mechanism to keep Scd5p phosphorylation 

















Effects of Scd5p phosphorylation by Prk1p on protein-protein interactions.   
Two-hybrid interactions of wild-type [SCD5] and constitutively dephosphorylated 
[SCD5AAA] and phosphorylated [SCD5EEE] Scd5p with A. Pan1p, B. End3p, C. Glc7p. 
 
All these data led us to speculate on the possible significance of Scd5p 
phosphorylation by Prk1p. Since phosphorylation of Scd5p reduces its affinity for 
Pan1p and End3p, it may cause Scd5p-Glc7p complex to be uncoupled from End3p 
and the already phosphorylated Pan1p, thus prevent undesired reverting of 
phosphorylation, which could otherwise impede coat disassembly. If this is the case, 
one can expect the phosphorylation of Pan1p by Prk1p to be suppressed in the non-
phosphorylatable scd5AAA mutant. To test this prediction, we over-expressed the PRK1 
gene from the GAL1 promoter to enhance the Pan1p phosphorylation in vivo. The 




of kinase over-expression. In contrast, the scd5AAA mutant, whose steady-state Pan1p 
phosphorylation level was already lower before the induction, only showed a slight 
increase under the same conditions [Fig. 5-13A and B]. This result well supports the 













The effect of SCD5AAA mutation on Prk1p-induced Pan1p phosphorylation.   
A. YMC471 and YMC473 cells containing pGAL-PRK1-313 were allowed to grow 
at 30°C to log phase in raffinose, followed by addition of galactose. Samples 
were taken at different time points as indicated. Pan1-Myc was 
immunoprecipitated, electrophoresed and immunoblotted with anti-PThr and then 
anti-Myc antibodies.   
B. Calculation of the relative phosphorylation intensity of Pan1-Myc in Fig. 4e.  The 
phosphorylation level of Pan1-Myc in each lane was measured by densitometer 
and normalized against its protein amount. The relative phosphorylation 
intensities of all lanes were calculated against lane 1. 
 
5.2.I   Steady-state phosphorylation level correlates with patch life-time of Pan1p 
 
Toshima et al have shown that overexpression of Prk1p will mislocalize 
Pan1p-GFP to the cytosol (Toshima et al., 2006), implying that excess kinase activity 




activity in a different scenario when the phosphatase targeting factors are defective or 
deleted. In accord with this hypothesis, Pan1p was demonstrated to be 
hyperphosphorylated in scd5-1 or end3Δ mutants [Fig. 5-5] as a result of 
compromised dephosphorylation. Strikingly similar to cells overexpressing Prk1p, 
end3Δ  mutant also caused loss of patch localization for Pan1-GFP (Kaksonen et al., 
2005). Therefore, these 2 scenarios led to the same effect that the phosphatase is 
overpowered by the kinase and Pan1p are profoundly hyperphosphorylated and 
unable to be reactivated by the dephosphorylation machinery.  
Since we have established that Glc7p acts on Pan1p through its targeting 
factor End3p-Scd5p, one would expect that overproducing the phosphatase itself or 
the targeting factors may promote dephosphorylation and reduce the steady state 
phosphorylation level of Pan1p. To explore this possibility, 2μ multicopy expression 
constructs [pRS424] were used to over-express Glc7p, Scd5p, End3p and its two 
truncations in WT cells. As expected, multicopy GLC7 is able to reduce Pan1p 
phosphorylation level markedly [Fig. 5-14A, lane 1 and 2]. Similar extent of hypo-
phosphorylaion was observed when overexpressing the targeting factors Scd5p [lane 3] 
and End3p [lane 4]. Interestingly, the N- and C-terminus truncation of End3p led to 
contrasting effects [lane 5 and 6]. Evidently, multicopy END3-ΔN was almost totally 
ineffective to promote the dephosphorylation of Pan1p [lane 5]. To rule out the 
possibility that the END3-ΔN-pRS424 construct may not be functional, it was 
transformed into end3Δ cells and examined for its ability to suppress the TS 
phenotype. It was then revealed that this END3-ΔN plasmid could support the growth 
of end3Δ cells at 37 oC [data not shown], confirming that the construct produces 
functional truncated End3p. Therefore, END3-ΔN-pRS424 indeed had no effects in 











Dephosphorylation increases Pan1p patch lifetime significantly.   
A. YMC441 cells were transformed with various 2μ plasmids overexpressing various 
proteins [lane 2-6] and the vector control [lane 1] and grown at 30°C.  
Endogenously expressed Pan1-Myc was immunoprecipitated from these cells and 
sequentially immunoblotted with anti-PThr and anti-Myc antibodies. 
B. Lifetime of Pan1-GFP patches in YMC494 cells transformed with pEND3-424 or 
pSCD5-424 and in YMC449 cells [SCD5AAA]. n ≥ 30 patches. 
 
Surprisingly the other truncation END3-ΔC when overexpressed was able to reduce 
Pan1p phosphorylation as effectively as the full-length protein does [lane 4 and 6]. 
Hence, this result became puzzling as END3-ΔC was shown to be sufficient to recruit 
Scd5p-Glc7p [Fig. 5-4] but incompetent to bind to Pan1p (Tang et al., 1997), thus was 
expected to be just as ineffective as END3-ΔN. This can be explained by the 
possibility that END3-ΔC may bind Sla1p (Tang et al., 1997), which is also in 
complex with Pan1p, hence indirectly channel Scd5p-Glc7p to Pan1p.  
In previous section, it has been shown that SCD5AAA also causes a reduction of 
Pan1p phosphorylation level [Fig. 5-13]. It was thought that phosphorylation of Scd5p 
by Prk1p is critical for uncoupling the phosphatase from the coat proteins and 
preventing it from dephosphorylating Pan1p too early. We then reason that SCD5AAA 




dephosphorylation of Pan1p during the Prk1p-driven coat disassembly process. Hence, 
a delay in Pan1p patch disappearance might occur. In agreement with this prediction, 
the average Pan1p patch lifetime has been extended from 29 sec to 36 sec in SCD5AAA 
cells, indicating a significant delay in coat disassembly. In the case of multicopy 
expression of Glc7p-targeting proteins End3p and Scd5p, more cytosolic Glc7p could 
be recruited to the endocytic coat. Therefore, premature dephosphorylation of Pan1p 
may occur and result in a similar prolonged Pan1p patch phase observed in Scd5AAA. 
Indeed, overexpressing End3p and Scd5p extended the lifetime of Pan1p patch to 40 
and 46 seconds respectively. Evidently, how much the lifetime of Pan1p patch has 
been prolonged corroborates positively with how much the steady-state 
phosphorylation level of Pan1p has been reduced. To illustrate this correlation, 2μ-
SCD5 led to the greatest decrease in the phosphorylation level of Pan1p, followed by 
2μ-END3 and SCD5AAA mutation [Fig. 5-14A and Fig.5-13B]. The same order was 
then observed when the extensions in Pan1p lifetimes were ranked [Fig. 5-14B].  
All these data illustrate well that the dynamic phosphoregulation of Pan1p 
requires the balance between the kinase and the phosphatase. Enhancing or 

















5.3.A   Working model for the phosphoregulation of Pan1p during endocytosis 
Previously our understanding of phosphoregulation of actin-coupled 
endocytosis in yeast had been limited to the actions of the Prk1p family of kinases. 
Now we show that the phosphatase Glc7p is responsible for the dephosphorylation of 
Pan1p. The spatiotemporal dynamics between the substrate [Pan1p], the kinase [Prk1p] 
and the phosphatase [Glc7p] have not been adequately studied, although we have 
demonstrated the accurate coincidence between Scd5p and Pan1p patches [Fig. 5-2]. 
A few outstanding questions are yet to be answered.  
The first unanswered question is how Prk1p patch behaves so as to promote 
coat protein phosphorylation? Thus far only static fluorescent microscopic images 
were available to show Prk1p localization with the actin network (Cope et al., 1999; 
Zeng & Cai, 1999). It was later confirmed that Prk1p was probably recruited by 
Abp1p to the actin as deleting the region required for Abp1p-binding in Prk1p 
rendered a complete loss of its cortical localization (Fazi et al., 2002). To study its 
patch dynamics, real-time imaging was carried out. It was then found that, the Prk1-
GFP patches had a shorter lifetime [about 17 s, Fig. 5-15B] and higher motility than 
Pan1-GFP patch observed earlier on [Fig. 5-2]. Two-color imaging revealed that 
Prk1-GFP was recruited to cortical patches at the same point as Abp1-RFP, and the 
two proteins also disappeared together in the end [Fig. 5-15E]. Therefore, Abp1p and 
Prk1p share an identical spatiotemporal pattern, corroborating the notion that Prk1p is 
recruited to the actin network by Abp1p. Two-color imaging for Prk1p and Pan1p 
demonstrated that, Prk1-GFP joined the Pan1-CFP patches at a much later stage, just 
a few seconds before Pan1-CFP began to fade. It coexisted with Pan1-CFP 























Live cell imaging of Pan1p, Abp1p and Prk1p patches. 
A. Single frames from movies of live cells expressing Pan1-GFP [YMC494], and 
Prk1-GFP [YMC495].  Movies were taken with the frame intervals of 2 s for 
Pan1-GFP and Prk1-GFP.   
B. Lifetimes of Pan1-GFP and Prk1-GFP patches in wild-type cells.   n ≥ 30 for each 
protein.  
C. Time series from two-color movies showing the dynamic localization of Prk1-GFP 
in reference to Pan1-CFP. Interval between frames is 3 s. 
D. Plots of patch fluorescence intensities in C with time.   
E. Time series from two-color movies showing the dynamic localization of Prk1-GFP 




D]. These data confirm that Pan1p [and thus Scd5p] is phosphorylated by the Abp1p-
recruited Prk1p kinase, which leads to its dissociation from the cortical patch and 
endocytic coat disassembly.  
Another critical question is whether Glc7p indeed forms a complex with 
cortical Scd5p. The association of Glc7p and Scd5p has been validated exclusively 
with biochemical binding assays throughout the literature (Chang et al., 2002; Tu et 
al., 1996). The localization of Scd5p was found to be cortical (Chang et al., 2006; 
Henry et al., 2002), in agreement with our current data showing the colocalization of 
Pan1p and Scd5p [Fig. 5-2]. For Glc7p, many reports have shown that it is mainly 
nucleus-localized with some cytoplasmic localization (Bloecher & Tatchell, 2000; 
Knaus et al., 2005; Kozubowski et al., 2003; Zhang et al., 1995). However punctate 
structures near the cell cortex similar to Scd5p localization are seldom observed in 
WT cells. Two possible reasons may explain the lack of cortical localization of Glc7p. 
One is that Scd5p is low in abundance with only 700 copies per cell (Ghaemmaghami 
et al., 2003). Assuming Scd5p-Glc7p complex is 1:1 in stoichiometry, cortical Glc7p 
should not be more than 700 copies, which is less than 5% of the total cellular Glc7p 
of 14600 copies (Ghaemmaghami et al., 2003). It is likely that the strong nuclear 
concentration of Glc7p may be so bright in fluorescence that it overshines the 
relatively faint cortical signals. The other probable reason is that Glc7p is unable to 
bind Scd5p strongly while it is also in complex with End3p and Pan1p. Although the 
binding region of Glc7p in Scd5p (Chang et al., 2002) is independent from that of 
Pan1p [N2, Fig. 5-1], it may overlap with that of End3p binding region [Fig. 5-4 and 
data not shown]. Therefore, it is likely that Glc7p binding to Scd5p is sterically 
hindered, resulting in little cortical patch localization. The complex between Scd5p 
and Glc7p could be optimal only immediately after Prk1p drives the complete 
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disassembly of the coat complex. However, the colocalization between Glc7p and 
Scd5p may be possible when Scd5p is overexpressed as a recent study showing that 
overexpression of two other targeting subunits Gip3 and Gip4 titrated Glc7 away from 
the nucleus to the cytoplasm (Pinsky et al., 2006). This lack of bright spots at the 
cortex also suggests that Glc7p dephosphorylates relevant substrates mainly in the 
cytosol. Consistently, it was reported that normal functions of actin cytoskeleton and 
endocytosis do not require cortical localization of Scd5p [thus colocalization with 
Pan1p] since these functions remain intact in a scd5 mutant in which no cortical but 
all cytosolic Scd5p was observed (Chang et al., 2006). Furthermore, another scd5 
mutant [scd5-Δ338] causes almost a total nuclear translocation of the protein and 
exhibits TS phenotype (Chang et al., 2006). Deletion of PRK1 gene is able to suppress 
this particular mutant (Henry et al., 2003), presumably by offsetting the lack of 
cytosolic Scd5p and its mediated dephosphorylation activity. All these data indicate 
that it is the cytosol where Glc7p-Scd5p complex performs dephosphorylation of 
Pan1p and other phosphoproteins. Hence, the cortical localization of Glc7p is not a 
must for this aspect of its activity.  
The above findings with work of others allow us to offer a model of a 
complete cycle of the phosphoregulation of Pan1p during endocytosis [Fig. 5-16]: [1] 
Assembly of the endocytic complex at the site of endocytosis, in which Pan1p is 
complexed with End3p and Scd5p together with other coat proteins and present in an 
unphosphorylated state. [2] Initiation of actin polymerization by the Arp2/3p complex 
to induce membrane invagination. [3] Vesicle scission and inward movement 
propelled by actin polymerization. [4] Phosphorylation of Scd5p and Pan1p by Prk1p 
to disassemble the coat complex. Incorporation of the kinase into the complex at this 
stage involves Abp1p (Fazi et al., 2002), which appears on the Pan1p patches at about 
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same time as Prk1p [Fig. 5-15E]. The kinase starts by phosphorylating and 
dissociating Scd5p from Pan1p and End3p so that extensive phosphorylation of Pan1p 
can be carried out. This will cause rapid distortion/disruption of the interactions 
among endocytic coat proteins. [5] Recovery of Pan1p from the phosphoinhibition. 
After dissociation from the endocytic complex, Scd5p is immediately 
dephosphorylated by Glc7p, whose association with Scd5p is unaffected by Prk1p 
phosphorylation. Dephosphorylation of Pan1p starts by re-association of Scd5p with 
End3p, which has been kept in a somewhat loose contact with Pan1p. Once it 
initiates, dephosphorylation of Pan1p is expected to be a self-accelerating process, as 
the first cluster of phosphor residues to be cleared are most likely those located in the 
End3p- and Scd5p-binding region [LR2], and dephosphorylation in this region will 
result in a more secured interaction of Pan1p with both End3p and Scd5p. This will in 
turn facilitate the dephosphorylation of another cluster of sites located in the LR1 
region. Dephosphorylated Pan1p, remained in a complex with End3p-Scd5p-Glc7p, is 
now once again ready to lead the next round of endocytosis [Fig. 5-16].   
 
5.3.B   In vitro reconstitution of the phospho-regulation of Pan1p by Glc7p 
The capability of Glc7p in directly dephosphorylating various endocytic 
proteins including Pan1p and Scd5p was confirmed in our in vitro phosphatase assays 
[Fig. 5-9, 5-10 and 5-11]. However, the role of End3p in promoting Glc7p activity has 
not been demonstrated in vitro. The reason is that in our current in vitro assay system, 
Glc7p input was in excess relative to the amount of the substrate. Therefore, the direct 
dephosphorylation reactions already occur with appreciable kinetics in the absence of 
phosphatase targeting factors. Future prospective studies should include setting up a 






Model of the dynamic assembly and disassembly of the actin-driven endocytic 
machinery with an emphasis on phosphoregulation of Pan1p by Prk1p and 
Glc7p. [1]. Coat assembly. [2]. Initiation of actin polymerization. [3]. Vesicle 




First, the relative input of the substrate and the phosphatase should be close to their 
physiological concentrations. Glc7p will not be in excess relative to the substrate. 
Only when the phosphatase is limiting, can the possible dephosphorylation-
stimulating activities of Scd5p-End3p be examined by monitoring any increase in 
reaction rate upon addition of these factors. Secondly, prepare the native full-length 
proteins from yeast as the substrates with TAP-tagging approach, instead of the 
bacterially expressed GST-fusions. Endogenous proteins even in their native complex 




assay in order to model the phosphatase action as close as possible to the 
physiological environment. Therefore, the new phosphatase assay system will 
definitely help us reconstitute the dephosphorylation process in vitro.  
 
 
5.3.C   Dephosphorylation of other phospho-endocytic proteins 
In addition to Pan1p and Scd5p, other endocytic proteins that are known to be 
phosphorylated by Prk1p, such as Sla1p, Ent1/2p and yAP1801/2p (Huang et al., 
2003; Watson et al., 2001; Zeng et al., 2001), may also be dephosphorylated by 
Glc7p, and the dephosphorylation may be dependent on Scd5p as well. For instance, 
the yeast homologue of mammalian Huntingtin-interacting protein 1R [HIP1R], 
Sla2p, which contains two Prk1p phosphorylation motifs [Fig. 4-4], has been reported 
to be involved in interactions with Ark1p and Scd5p (Cope et al., 1999; Henry et al., 
2002).  Therefore, it will be interesting to find out whether Sla2p is phosphoregulated 
by Prk1p/Ark1p and Glc7p in a similar fashion as Pan1p. 
Among all the endocytic proteins, besides Scd5p, Sla1p was also reported to 
interact with Glc7p (Tu et al., 1996; Venturi et al., 2000) again in a yeast two-hybrid 
screening for Glc7p binding partners. However, it could not be verified in our yeast 
two-hybrid system and in vitro binding either [data not shown].  
Interestingly the canonical PP1-binding motifs [RK] [VI]xF or  [RK]x[VI]xF 
are found to be present in numerous other Prk1p targets besides Scd5p. For instance, a 
copy of KEIKF from a.a. 274 to 278 is located right next to the two Prk1p 
phosphorylation motifs in Sla2p [Fig. 4-4]. Future work is to determine whether this 
PBM is functional to target Glc7p to dephosphorylate Sla2p. Another endocytic 
protein that contains one candidate PBM is the clathrin adaptor yAP1801p. In this 
protein, a potential motif HTVNF from a.a. 396 to 400 sits immediately N-terminal to 
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the three Prk1p phosphorylation sites [Fig. 3-4A]. Likewise, it will be intriguing to 
explore the relevance of this PBM in mediating dephosphorylation by Glc7p.  
 
5.3.D   Alternative dephosphorylation pathway 
We have demonstrated that End3p-Scd5p provides the missing link between 
Glc7p and phosphorylated Pan1p. Whether this is the sole entry point through which 
the phosphatase gains access to Pan1p and/or other endocytic proteins that are 
phosphorylated by Prk1p, remains elusive. In fact, Glc7p was scored as a Pan1p-
binding partner in a large-scale genome-wide yeast two-hybrid analysis (Uetz et al., 
2000). If this were true, Pan1p could be directly accessed by Glc7p without the 
necessity of specific targeting subunits. Then the absence of functional End3p or 
Scd5p should not have affected proper dephosphorylation of Pan1p at all, which was 
clearly not the case based on our data. In any case, we attempted to verify Pan1p-
Glc7p interaction by yeast two-hybrid assay and in vitro binding experiments, but to 
no avail [data not shown]. Therefore we conclude that the Pan1p-Glc7p interaction hit 
was either indirect or false positive and it is highly unlikely that Glc7p is able to 
dephosphorylate Pan1p independent of End3p-Scd5p.  
 
5.3.E   Possible role of Glc7p-related phosphatases in endocytosis 
An important role of Glc7p in the endocytic process has been clearly 
illustrated thus far. In yeast genome, there are three other related phosphatases whose 
catalytic domain shares substantial degree of identity with that of Glc7p, namely, 
Ppz1p, Pzz2p and Sal6p. First hint of the functional redundancy among these related 
phosphatases came from an alanine scanning effort. Very few of the missense 
mutations created at the highly conserved residues of Glc7p led to conditional growth 
  
127Chapter 5 
phenotypes (Baker et al., 1997). Second hint is that , ppz1 and ppz2 null mutants were 
shown to display synthetic growth defects or even lethality in combination with 
mutant alleles of glc7 (Venturi et al., 2000). Therefore, these three phosphatases were 
thought to have overlapping functions with Glc7p.  
A plethora of Glc7p regulatory subunits have been identified, reflecting the 
many roles that this phosphatase plays in cellular processes. Interestingly, Ppz1p was 
found to interact strongly with a number of these Glc7p-targeting subunits, including 
Scd5p (Venturi et al., 2000). Hence, Ppz1p can also be potentially targeted to 
endocytic proteins by Scd5p. However, the most studied function of Ppz1 is to 
maintain potassium homeostasis and the protein is strictly localized at the plasma 
membrane (Yenush et al., 2005; Yenush et al., 2002). As dephosphorylation of Pan1p 
is a cytosolic process, the localization pattern of Ppz1p should mitigate the possibility 
that it may dephosphorylate Pan1p. Hence, the strong binding between Scd5p and 
Ppz1p measured in yeast two-hybrid assays, is probably due to the non-specific 
interactions made by phosphatase catalytic domain [used in the assay], which is 
highly homologous [63% in identity] to Glc7p. The genetic interactions observed 
between Glc7p and Ppz proteins could be explained by the possibility that each 
phosphatase would have substrates that it is uniquely capable of dephosphorylating, 
whereas other substrates are shared by all three. Pan1p may belong to the class of 
unique substrates for Glc7p.  
 
5.3.F   Phosphorylation status of Pan1p may affect its stability 
Previously we showed that in the absence of functional Scd5p [scd5-1] and 
End3p [end3Δ], Pan1p tends to be hyperphosphorylated [Fig. 5-5]. Curiously, we 
have also observed a dramatic reduction in full-length Pan1-myc level accompanied 
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with an elevation in protein phosphorylation status in these two mutants in 
comparison to WT cells. Shown in Fig. 5-17, total cell lysates for 
immunoprecipitation were normalized by housekeeping protein G6PDH. At 
permissive temperature, scd5-1 and end3Δ mutants express only a 23% and 17% of 
full-length Pan1p level in WT. Upon shifting to 37oC, further loss of full-length 
Pan1p protein to a mere 2% of WT level was observed for both mutants. In order to 
detect the protein band, 5-fold more concentrated lysates [visualized by α-G6PDH 
loading] were used for the immunoprecipitation of Pan1p-myc in these two mutants 
than WT cells.  In contrast, temperature shift had little effect on Pan1p level in WT 
cells. Likewise in end3 truncation mutants [Fig. 5-6] and PRK1-overexpressing cells 
[Fig. 5-13], Pan1p expression level apparently reversely correlates with the extent of 
hyperphosphorylation. All these data suggest that hyperphosphorylation due to 
unchecked phosphoregulation led to rapid turnover of Pan1p. However the 
mechanism of this hyperphosphorylation-induced protein degradation is unclear.  
Conversely, Pan1p protein level markedly increased when overexpressing 
Glc7p or its two targeting factors End3p and Scd5p [data now shown]. Shown in Fig. 
5-14, Pan1p is protected from being phosphorylated in these cells, suggesting that 
hypo-phosphorylated Pan1p seems to be protected from degradation. However, not all 
data agree with this assumption. Full-length Pan1p expression level was slightly 
reduced in prk1Δ and sla1Δ mutant in comparison with WT cells [data now shown], 
although the Pan1p phosphorylation status has dropped to 15 % of the level of WT in 









Hyperphosphorylation induces rapid degradation of Pan1p. 
Endogenously expressed Pan1-Myc was immunoprecipitated from cells and 
sequentially immunoblotted with anti-PThr and anti-Myc antibodies. The full-length 
Pan1p-myc level of each lane was measured by densitometer and normalized against 
its G6PDH loading control. The relative protein expression level were then calculated 
and presented as bar graphs [right panels]. 
A. Pan1-Myc from YMC441 [lanes 1 and 3, 5-fold dilution], and YMC479 [lanes 2 
and 4] cells at either 25°C [lanes 1-2] or 37°C for 3 h [lanes 3-4].  
B. Pan1-Myc from YMC441 [lanes 1 and 3, 5-fold dilution] and YMC480 [lanes 2 







































 131Chapter 6 
Here is a summary of my thesis work described in Chapters 3 to 5. 
This thesis work has been carried out in the context of endocytic regulation. 
Referring to Fig. 3-16, an endocytic process is initiated by coat proteins that are 
responsible for selecting endocytic sites and stimulating clathrin assembly. Actin 
polymerization is subsequently launched and coupled with the invaginating vesicle. 
Shortly after the nascent vesicle is formed by scission, actin polymerization activity is 
disengaged from the vesicle and eventually shut off. Proteinaceous vesicle coat then 
has to be disintegrated and removed from the vesicle to enable its fusion with the 
endosome. 
Work from our lab (Zeng & Cai, 1999; Zeng et al., 2001) and others (Toshima 
et al., 2005) has corroborated an important role of the threonine kinase Prk1p in the 
disassembly of the vesicle coat. Prk1p was shown to phosphorylate coat proteins 
Pan1p and Sla1p on threonine residues lying in the motif LxxQxTG and promote the 
disassembly of Pan1p-Sla1p-End3p trimeric complex (Zeng & Cai, 1999; Zeng et al., 
2001).  
In Chapter 3, I first explored the limitation of the original Prk1p 
phosphorylation consensus motif LxxQxTG (Zeng & Cai, 1999). Efforts using the 
directed mutagenesis approach and in vitro kinase assays were made to determine the 
amino acid requirement at P-5 and P-2 positions respectively. Thus the minimal 
phosphorylation motif for Prk1p was established as [L/I/V/M]xxxxTG.  
In Chapter 4, I then searched the yeast proteome for putative Prk1p substrates 
containing the newly defined Prk1p target sequence. Not only new sites were found in 
known substrates, but also numerous novel substrates were predicted. Furthermore, 
endocytic protein Scd5p was selected and tested to be a true Prk1p target in vivo.  
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In Chapter 5, I went on to demonstrate that Scd5p is the key to one of the 
most long-standing questions in the field of endocytic regulation. What was of great 
interest and yet of little knowledge is that how the endocytic factors including Pan1p 
and Sla1p can be relieved from phospho-inhibition inflicted by the kinase Prk1p. 
Scd5p, forming a complex with type I phosphatase [encoded by GLC7], is able to 
bridge the gap between phosphatase activity to the phosphorylated Pan1p. Two 
targeting routes for the Glc7p-Scd5p complex to Pan1p were uncovered. First, a direct 
route. Scd5p was able to bind Pan1p physically. Second, an indirect and perhaps a 
preferred route. Scd5p has a high affinity for End3p, a binding partner of Pan1p. The 
interaction between Scd5p-End3p pair was 10 times stronger than that between 
Scd5p-Pan1p based on quantitative yeast two-hybrid data. Altogether, Scd5p serves as 
a targeting subunit of type I phosphatase for the purpose of dephosphorylating Pan1p.  
To summarize, the major findings of the previous chapters have been the basis 
of the conclusions drawn in the subsequent chapters. The three chapters [Chapters 3-
5] constitute a much improved understanding of the regulatory complexity of actin-
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